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Vascular Ehlers-Danlos syndrome is a heritable disease of connective tissue
caused by mutations in COL3A1, conferring a tissue deficiency of type III collagen.
Cutaneous wounds heal poorly in these patients, and they are susceptible to spontaneous
and catastrophic rupture of expansible hollow organs like the gut, uterus, and mediumsized to large arteries, which leads to premature death. Although the predisposition for
organ rupture is often attributed to inherent tissue fragility, investigation of arteries from
a haploinsufficient Col3a1 mouse model (Col3a1+/-) demonstrates that mutant arteries
withstand even supraphysiologic pressures comparably to wild-type vessels. We
hypothesize that injury that elicits occlusive thrombi instead unmasks defective
thrombus resolution resulting from impaired production of type III collagen, which
causes deranged remodeling of matrix, persistent inflammation, and dysregulated
behavior by resident myofibroblasts, culminating in the development of penetrating
neovascular channels that disrupt the mechanical integrity of the arterial wall.
Vascular injury and thrombus formation following ligation of the carotid artery
reveals an abnormal persistence and elevated burden of occlusive thrombi at 21 postv

operative days in vessels from Col3a1+/- mice, as opposed to near complete resolution
and formation of a patent and mature neointima in wild-type mice. At only 14 days,
both groups harbor comparable burdens of resolving thrombi, but wild-type mice
increase production of type III collagen in actively resolving tissues, while mutant mice
do not. Rather, thrombi in mutant mice contain higher burdens of macrophages and
proliferative myofibroblasts, which persist through 21 days while wild-type thrombi,
inflammatory cells, and proliferation all regress. At the same time that increased
macrophage burdens were observed at 14 and 21 days post ligation, the medial layer of
mutant arterial walls concurrently harbored a significantly higher incidence of
penetrating neovessels compared with those in wild-type mice.
To assess whether limited type III collagen production alters myofibroblast
behavior, fibroblasts from vEDS patients with COL3A1 missense mutations were seeded
into three-dimensional fibrin gel constructs and stimulated with transforming growth
factor-β1 to initiate myofibroblast differentiation. Although early signaling events occur
similarly in all cell lines, late extracellular matrix- and mechanically-regulated events
like transcriptional upregulation of type I and type III collagen secretion are delayed in
mutant cultures, while transcription of genes encoding intracellular contractile
machinery is increased. Sophisticated imaging of collagen synthesized de novo by
resident myofibroblasts visualizes complex matrix reorganization by control cells but
only meager remodeling by COL3A1 mutant cells, concordant with their compensatory
contraction to maintain tension in the matrix.
Finally, administration of immunosuppressive rapamycin to mice following
carotid ligation sufficiently halts the initial inflammatory phase of thrombus resolution
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and fully prevents both myofibroblast migration into the thrombus and the differential
development of neovessels between mutant and wild-type mice, suggesting that
pathological defects in mutant arteries develop secondarily to myofibroblast dysfunction
and chronic inflammatory stimulation, rather than as a manifestation of tissue fragility.
Together these data establish evidence that pathological defects in the vessel wall
architecture develop in mutant arteries as sequelae to abnormal healing and remodeling
responses activated by arterial injury. Thus, these data support the hypothesis that
events threatening the integrity of type III collagen-deficient vessels develop not as a
result of inherent tissue weakness and fragility at baseline but instead as an episodic
byproduct of abnormally persistent granulation tissue and fibroproliferative intravascular
remodeling.
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Chapter 1: Introduction

1

Vascular Ehlers-Danlos Syndrome and Type III Collagen
Ehlers-Danlos syndrome describes a group of heritable multiorgan diseases that
share features of abnormal skin and loose joints, and often the causative genetic
mutations severely impinge on the structural integrity of collagen in the extracellular
matrix. The symptoms and signs associated with type IV, otherwise known as vascular
type Ehlers-Danlos syndrome (vEDS) and the most malignant of all types, occur as a
result of autosomal dominant mutations in COL3A1 that alter the biosynthesis of type III
collagen2-5. Type III collagen forms as a super-helix of three α1(III) polypeptides each
encoded by COL3A1 and containing large regions of ~330 -Gly-X-Y- repeats. Such
glycine residues are essential to super-helical structure as a function of their minimal
side chains, which occupy the spatially-limited central channel of the assembled
trimers2. However, heterozygous missense mutations associated with vEDS (the most
common alterations, followed by exon skip mutations) instead encode amino acid
substitutions for an essential glycine residue in half of the α1(III) monomers produced6.
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Figure 1.1. Fibroblast assembly of collagen fibrils. Panel A shows intracellular
post-translational modifications of proα chains, association of C-propeptide domains,
and folding into triple-helical conformation. Gal denotes galactose, Glc glucose,
GlcNac N-acetylglucosamine, and (Man)n mannose residues. Panel B shows
enzymatic cleavage of procollagen to collagen, self-assembly of collagen monomers
into fibrils, and cross-linking of fibrils. Reprinted with permission from
Massachusetts Medical Society [Heritable diseases of collagen. Prockop DJ,
Kivirikko K. New England Journal of Medicine. 1984].
Once the synthesized α1(III) monomers mature via post-transcriptional
modification in the endoplasmic reticulum, a nidus spontaneously associates the Ctermini of three chains and propagates association toward the N-terminus like a zipper to
manufacture the triple helix. After secretion of soluble procollagen, proteinases cleave
propeptides at both termini, allowing the highly ordered helical domain to selfpolymerize into cross-striated fibrils of insoluble molecules regularly staggered along
the fibrillar axis7 (Figure 1.1). Type III collagen shares this ability with type I, II, V, and
XI collagens, which together comprise the family of fibrillar collagens2.
Under the influence of COL3A1 missense or exon skip mutations, on the other
hand, structurally altered monomers lead to retention of partially-assembled type III
3

procollagen trimers within the endoplasmic reticulum and inhibit the extracellular
accumulation of mature type III collagen as a dominant negative effect8,9. Presumably,
assembly of homotrimers from a pool of monomers in which one-half is defective would
produce altered structures in seven-eighths of resulting polymers, while only the normal
one-eighth would proceed to secretion9. However, the severity of type III procollagen
retention in fibroblasts from vEDS patients varies more extensively than this would
predict and corresponds to the proximity of glycine substitutions or skipped exons to the
C-terminus, where trimerization initiates9. Interestingly, the location of mutations also
produces a measurable effect on the size and heterogeneity in diameter of extracellular
collagen fibrils formed mostly by type I collagen, as C-terminal mutations lead to
smaller fibrils overall while N-terminal mutations lead to wider variability and
sometimes higher average diameter9 (Figure 1.2). This effect occurs despite the
theoretical concept that any extracellular type III collagen secreted would be structurally
normal in all genetic scenarios, perhaps implicating the specific genotype's effect on the
rate of type III collagen secretion, in addition to a generalized effect depressing steadystate levels, in the development of pathologically heterogeneous matrix with either
abnormally small or large collagen fibrils. At the same time, this particular correlation
between genotype and phenotype at the level of cellular production of collagen does not
extend to the level of an individual patient's risk for severe clinical complication10,11.
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Figure 1.2. In EDS type IV with glycine substitution and exon skip mutations,
the change in size and distribution of collagen fibril diameters compared to
controls depends on the mutation. Collagen fibril diameters in the reticular
dermis of individuals with EDS type IV (––) are plotted with similar
measurements for sex-matched controls (····). The range of fibril diameters is
slightly greater in EDS type IV compared to the control. Reprinted with
permission from Nature Publishing Group [Mutations in the COL3A1 gene result
in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution
of the major collagen fibrils of the dermis. Smith LT, Schwarze U, Goldstein J,
Byers PH. Journal of Investigative Dermatology. 1997].
5

Clinical Effects of Vascular Ehlers-Danlos Syndrome
The rigidity of the collagen triple helix contributes to the resistance against
compression or extension, defined as stiffness, in collagenous tissues2,12. This notion
likely contributes to the interpretation that tissues deficient in type III and type I collagen
are inherently fragile4,13,14. Clinical complications of vascular Ehlers-Danlos syndrome,
namely catastrophic rupture of hollow organs, would seem to support the idea that
abnormal collagen fibrils would directly lead to mechanical failure15. Nevertheless, a
closer examination of clinical features of vEDS reveals a more complicated and
perplexing picture of the disease. As stated above, the location or type of the most
common mutations, despite predicting the nature of baseline collagen derangement in
tissues9, does not predict clinical risk for type or frequency of major complication10.
The distribution of type III collagen among tissues is highest in distensible
organs, often hollow viscera, including the skin, arterial tree, bowel, and uterus2,10,16,
rather than in stiffer collagenous tissue like tendons, although type III collagen is
transiently abundant during the collagen fibrillogenesis of early tendon development17,18.
Life-threatening clinical complications of vEDS predictably occur in the organs
normally maintaining high levels of type III collagen into adulthood, including
dissection and rupture of large or medium-sized arteries (the most common cause of
premature death), bowel rupture and sepsis, and rupture of the gravid uterus during
labor. Although rare before puberty, as many as 25% of human patients with vEDS have
suffered a non-lethal but emergent complication by age 20, while 80% suffer at least one
complication by the age of 40 years. Overall, despite emergent intervention, median
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lifespan for these patients is 48 years, representing a dire prognosis and exceptionally
high risk of premature death4,10.
The most striking clinical characteristic of vEDS, however, is the relatively silent
attack of such catastrophic events, occurring with little or no premonitory signs or
symptoms, such that patients often remain undiagnosed (or incorrectly diagnosed for
more minor complications like easy bruising) until such major catastrophic episodes
spontaneously present themselves6,10,16. This particular feature of the disease defies the
simplicity of the hypothesis that less collagen in the tissues directly causes tissue
fragility, as low levels of type III collagen would presumably exist all of the time and the
vast majority of the time without major incident. Thus, it is much more likely that
additional covert events, i.e., multiple hits accumulating over a lifetime, converge to
overwhelm the structural integrity of type III collagen-deficient organs.
A relevant example of covert events involving the hollow, distensible organs in
question is the matrix remodeling these tissues undergo episodically throughout adult
life to repair intraluminal injuries. These include thrombus formation and organization
in arteries19, mucosal ulceration in the gut20, and menstruation in the uterus21,22.
Remodeling also serves to mechanically adapt the walls of these organs in response to
dynamic intraluminal forces, such as blood pressure and pulsatile flow12,23,24, obstruction
of peristalsis25,26, and gestation, parturition, and involution of the uterus21,27.
Cutaneous wound healing supplies the ultimate, prototypical example of episodic
matrix remodeling following tissue injury, thanks to the vast literature of studies
describing its features (summarized by Singer and Clark28), so it should not be surprising
that vEDS patients also present to medical attention for skin findings and dystrophic
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wound healing. The most recent expert-recommended diagnostic criteria depend on
readily observable skin features and less severe cutaneous complications, designed for
their usefulness to generalist physicians in hopes of identifying patients with these rare
syndromes well before major complications occur. The most specific criteria include, of
course, organ rupture, as well as thin, translucent skin with easily visible veins over the
chest and abdomen, the characteristic facies of vEDS (thin, pinched nose, thin lips,
hollow cheeks, lobeless ears, and prominent staring eyes), and extensive bruising4.
Abnormal cutaneous scars in vEDS patients have been described as distended
and atrophic or papyraceous, but hypertrophic and fibrotic keloids also occur16,29.
Paradoxically, organ rupture always necessitates emergent surgery, but as a result it has
been well-documented that these patients often fare poorly in response to invasive
intervention, such that invasive diagnostics are contraindicated, pregnancy advised with
extreme caution, and surgery largely recommended only under imminent or frank threat
of life. Although surgeons note that internal tissues are friable with handling and
difficult to repair, the frequent and severe propensity for dehiscence of surgical wounds
and evisceration, fistulas, or adhesions threatens the post-operative course of even
successful procedures4,10,30.
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Figure 1.3. Distribution of 132 vascular complications in 24 patients with a clinical
diagnosis of Ehlers-Danlos syndrome type IV. Reprinted with permission from
Elsevier [The spectrum, management and clinical outcome of Ehlers-Danlos syndrome
type IV: a 30-year experience. Oderich GS, Panneton JM, Bower TC, et al. Journal
of Vascular Surgery. 2005].

Biomechanics of Large and Medium-Sized Arteries
As the most deadly complication in vEDS patients, the pathogenesis of the
dissection and/or rupture of large or medium-sized arteries merits the most urgent
attention by biomedical science. A retrospective survey of a cohort of vEDS patients
presenting to vascular surgeons revealed the incidence of vascular complications in these
arteries and their distribution throughout the body30 (Figure 1.3). Since dissection and/or
rupture of arteries represents biomechanical failure of the walls of these organs, an
understanding of normal properties of arterial wall architecture would illuminate more
fruitful avenues of further investigation. The functions of elastic and muscular arteries
and how these correlate with their different histological structures has been introduced
by Reid and Milewicz:
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"Structures of Arteries: Elastic Versus Muscular

The arterial system is an extensive and dynamic network of vessels
transporting blood under high pressure to deliver necessary nutrients and oxygen
throughout the body. Although blood vessels vary not only in size but also in
function, they share many basic structural elements. All arteries are composed of
three concentric layers, relative to the central lumen: the tunica intima, tunica
media, and tunica adventitia. The medial (middle) layer is composed largely of
highly specialized vascular smooth muscle cells (SMCs), which serve under
various circumstances both as the agents of contraction and as the manufacturers
of extracellular matrix, functions that provide structure and mechanical strength
to arteries to withstand the forces of fluid flow. The innermost intima consists of
a single layer of endothelial cells that abuts the lumen and is continuous with the
endocardium of the heart. The outer adventitial layer contains fibroblasts and the
collagenous connective tissues they produce, lymphatics, nerves, mast cells,
and—in the largest and thickest arteries—the vasa vasorum (the “vessels of the
vessels,” i.e., the smaller arteries supplying nutrients to the vessel wall itself).
The adventitia blends with the surrounding connective tissue and anchors the
artery to adjacent structures.
The structures of medial layers differ between types of arteries based on
location of an artery in the arterial tree and on the functional role of that artery in
controlling blood flow and pressure at that site. Large elastic arteries like the
aorta act as conduits of high-energy flow from the heart, accommodating the
volume pulse of systole through their high compliance. During diastole, these
arteries are then able to deliver the volume through their recoil, resulting in the
windkessel effect of dampened pulse pressures and more continuous flow
downstream. Thus bearing lower (but still relatively high) pressures, the
muscular distributing arteries form medium-sized branches that more precisely
direct flow toward end-organs yet still offer little resistance. Only within smaller
arterial branches and arterioles forming the final vascular beds of end-organs,
effectively forming parallel paths in the vascular circuit, does the contraction of
medial SMCs substantially decrease diameter enough to generate the resistance
to favor flow to some regions over others.
Large elastic arteries—such as the thoracic and abdominal aorta, common
carotids, pulmonary, and iliac arteries—are characterized by a medial layer
arranged into concentric lamellae (alternating layers of different materials)
formed by zigzagging elastic fibers interspersed with layer-spanning, helicallyoriented SMCs (Figure 1.4). This architecture allows the distending stress of
blood pressure to be distributed evenly throughout the vessel wall, and the
number of lamellar units in a vascular segment (as many as 56 in the ascending
aorta) varies linearly with tensional forces generated in the wall23. The
contractile units in SMCs are linked to the matrix scaffold in a manner similar to
how skeletal muscles are linked to bone. Sliding protein filaments extending
across the cytoplasms of SMCs are first linked to multiprotein transmembrane
clusters on the cell surface called focal adhesions, or dense plaques under
microscopy, which are in turn attached to bundles of microfibrils that extend
from the cell surface to the elastic fibers, thus forming a “contractile-elastin
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unit31.” These ordered units may help explain the properties of contracted
arteries (isometric contraction and stress relaxation) that allow these arteries to
withstand excessive distention, suggesting that even though the largest arteries do
not constrict against the high pressures they endure, their SMCs are still actively
regulating vessel caliber.

Figure 1.4. Schematic comparison of medial architecture in a muscular artery
(left) and an elastic artery (right). The media of a muscular artery is bordered
by the internal and external elastic laminae and contains overlapping and
concentrically-oriented smooth muscle cells. The media of an elastic artery
instead contains many elastic laminae alternating with muscular layers of
smooth muscle cells that each span the full thickness. The adventitia in a larger
elastic artery also contains small blood vessels (vasa vasorum) that nourish the
outer layers of the wall. [Arteries, Smooth Muscle Cells, and Genetic Causes of
Thoracic Aortic Aneurysms. Chapter 12: Inflammatory Diseases of the Blood
Vessels, 2nd ed. Reid AJ and Milewicz DM1].
In contrast, the medial layers of muscular distributing arteries—such as
the coronary, cerebral, renal, and mesenteric arteries—are composed of end-toend, concentrically overlapping SMCs and only two elastic fibers that delineate
the medial boundaries: the internal elastic lamina (between media and intima)
and the external elastic lamina (between media and adventitia). Bearing less
force, elastic fibers are not as essential to the function of muscular arteries32.
However, the medial layer continues to be the thickest layer, ranging from 40
SMCs in width down to as few as 6, suggesting that the SMCs must contribute
largely to the integrity of the vessel (Figure 1.4)."
Quoted text and figure reprinted with minimal modification and permission from
John Wiley and Sons [Arteries, Smooth Muscle Cells, and Genetic Causes of
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Thoracic Aortic Aneurysms. Chapter 12: Inflammatory Diseases of the Blood
Vessels, 2nd ed. Reid AJ and Milewicz DM1].
The major components of the arterial matrix in both types of arteries are elastin
and collagen, largely type I, but in differing ratios. Further discussion will be limited to
the matrix-derived properties of elastic arteries, since these arteries withstand higher
forces, conduct higher flow, and pose higher risk for fatal hemorrhage when ruptured,
but the biomechanical principles outlined here likely apply to the lower-pressure
muscular arteries as well, albeit to a lesser extent. Elastic arteries allowed the
evolutionary development of closed circulatory systems by providing the elastic
reservoir of the windkessel effect to distribute high energy input from the heart
continuously throughout the entire loop, as described above, and evolutionary trends
demonstrate the addition of elastin to less-sophisticated vessel matrices of collagen and
microfibrils with this increased complexity23.
The relative compositions of elastin and collagen in elastic vessels consequently
determine vessel distensibility, as described by mechanical relationships between stress
and strain. Circumferential strain (related to deformation) is defined as  =
circumferential stress in a thin-walled cylinder is defined as  =
radius,

∗

, where

∆


, and
is

is pressure, and ℎ is wall thickness. Stress is often discussed in hemodynamics

in the form of the Law of Laplace, where tension is  =

∗

, as tension provides a more

specific description of the strength of the wall material in opposing distending forces
acting to pull apart its component particles. Indeed, elastin fibers behave mechanically
like a polymer of long chains acting almost independently, as if unraveling and sliding
past each other with distention. Collagen fibers, on the other hand, are highly stabilized
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by interchain bonds in helices and regular cross-chain
chain striations in polymers (Figure 1.1)
that heavily resist sliding with distent
distention12.
Thus, the composite material properties of elastic arteries like the aorta have been
characterized as a "two-phase"
phase" model
model,, where the elasticity or stiffness of the vessel
approximates that of one or the other component in different mechanical scenarios.
scenarios
Overall, the vessel is less stiff than the stiffest component and more stiff than the lesser,
and absolute stiffness is a function of the cross
cross-sectional
sectional area occupied by each33. The


elastic modulus quantifies the stiffness of a material by relating stress to strain,
strain, =  ,
and a plot of stress or tension in elastic arteries as a function of strain or deformation is
nonlinear (Figure 1.5A),, i.e., not a constant ratio.. A calculation of incremental elastic

Figure 1.5. Nonlinear mechanical behavior of the adult mouse aorta. A:
A average
circumferential stress versus stretch ratio. B:: circumferential incremental elastic
modulus (Einc) versus stretch ratio. Einc was calculated by determining the local slope of
the stress-stretch
stretch ratio relationship in A. The physiological region is highlighted in gray
for each graph. Note the decreased incremental elastic modulus at low stretch ratios
where elastin dominates the vessel mechanical behavior and the increased modulus at
high stretch ratios where collagen dominates. The physiologic
physiological
al range is just at the
intersection of these two regions. The sharp increase in modulus just beyond the
physiological range prevents distention of, and damage to, the vessel with increased
pressure. Modified and reprinted with permission from The American
an Physiological
Society [Vascular extracellular matrix and arterial mechanics. Wagenseil JE, Mecham
RP. Physiological Reviews.. 2009].
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modulus, =

∆
∆

, represents the local slope, which at low strain is similar to the slope

of the modulus of elastin but is more similar to slope of the modulus of collagen at high
strain (Figure 1.5B). Thus, elastic arteries are highly extensible at low pressures (as
elastic fibers predominantly redistribute to bear increasing loads, going from wavy and
crumpled to straight) and appropriately compliant in response to pulse pressures in the
physiologic range (as less than 10% of rigid collagen fibers are engaged from
inconsistent arrangements at rest into circumferential orientation). At supraphysiologic
pressures, however, collagen fibers are quickly recruited into parallel order to achieve
rapid increases in tension and stiffness, limiting further distention12,23,33.
Fortunately, the two-phase material of elastic arteries provides a substantial
further benefit to wall integrity: two-phase materials may actually achieve higher tensile
strengths than the ultimate strength of the stronger component alone (Figure 1.5B). The
reality of structural defects and abnormally focused stresses often undermine the ideal
theoretical strength of a single material's intermolecular binding forces and cause
premature yield, much like a knot in a plank of wood represents the most likely place for
the plank to break. The two-phase material, on the other hand, takes advantage of the
more extensible component to distribute stresses more evenly, transferring focal stresses
by recruiting more remote fibers of the stiffer component. This serves to normally
prevent wall failure despite increasing incidence and size of irregularities in matrix
composition and structure with age33.
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Figure 1.6. Carotid artery parameters of vEDS and control subjects as measured
by vascular echography. IMT indicates intima-media thickness, WCSA indicates wall
cross-sectional area. Reprinted with permission from Wolters Kluwer Health [Increased
carotid wall stress in vascular Ehlers-Danlos syndrome. Boutouyrie P, Germain DP,
Fiessinger J-N, et al. Circulation. 2004].
In the case of vEDS, such irregularities likely exist at baseline, or occur more
frequently and earlier in life, because of the presumably deranged levels of collagen in
elastic arteries. In fact, a group of investigators noninvasively identified decreased
intima-media thickness in the common carotid arteries of a cohort of clearly dysmorphic
vEDS patients, although half had not suffered any vascular complications and more than
25% had not suffered any complications at all before the study. They concluded that
decreased wall thickness imposed a pulsatile circumferential stress on the carotids 22%
higher than that borne by arteries in control subjects, and that the carotids of vEDS
patients distended significantly more with systole, despite finding no differences in
blood pressure between the two groups. However, because of increases in strain
accompanying increases in stress, carotid arteries in the two groups also did not differ in
elastic modulus, or stiffness, and a wider variance for the vEDS patients suggests that
the arteries for some patients were actually more stiff (Figure 1.6). The investigators
15

interpreted their findings to mean that decreased thickness and increased wall stress
contribute to "tissue fragility" associated with vEDS13.
However, comparative vascular mechanics have elucidated the existence of a
universal elastic modulus in elastic arteries across species with different matrix
compositions, such that evolutionary pressure seems to favor a physiologic modulus in a
defined range of 0.3-1.0 MPa. Observers of this phenomenon speculate that this target
range, which both vEDS patients and control subjects from the study above occupy,
serves as an optimum for providing the recoil appropriate for large arteries in a closed
circulatory system and possibly guides the physiologic regulation of matrix remodeling
by cells native to these arteries23. Thus, decreased baseline collagen levels in vEDS
patients plausibly contribute to the thinning of the media in carotids, but further thinning
to re-equilibrate distensibility to a target modulus may actually represent a beneficial
adaptation to promote continuous blood flow. The clinical investigators above indeed
note that the extent of medial thinning in vEDS patients exceeds that expected from
estimated loss of collagen as a result of mutations and suggests that altered regulation of
vascular smooth muscle cell signaling contributes further to thinning13.
Nonetheless, considering the two-phase model of elastic arteries, decreased
cross-sectional area occupied by collagen could lower the ceiling of achievable tensile
strength33. Since elastic arteries in vEDS patients bear higher stress and must generate
higher tension at baseline, they are likely more vulnerable to episodes of excessive
stress. Additionally, and perhaps critically, they are also likely more vulnerable to the
influence of structural defects in the walls of their arteries, if fewer collagen fibers are
available for the redistribution of excessive focal stresses by elastin.

16

Trial of Celiprolol Decreases Incidence But Not Severity of Vascular Complications
Such a vulnerability to defects might help explain the again perplexing results of
a clinical trial aiming to reduce circumferential wall stress in the arteries of vEDS
patients. The same group measuring carotid artery wall thickness above suggested first
and then conducted a trial using vasodilating β-blockers to prevent vascular
complications of vEDS13,14. They chose celiprolol, a β1-adrenoceptor antagonist and
additional β2-adrenoceptor agonist with vasodilatory action, under the rationale that its
vasodilation of large conducting arteries in addition to resistance-generating arterioles
would reduce local pulse pressure in the elastic arteries proximal to the heart13. In
theory, the reduction in local pulse pressure would counteract the decrease in local wall
thickness and outweigh the increase in radius to restore normal circumferential wall
stresses ( =

↓↓ ∗ ↑
↓

).

Surprisingly, celiprolol elicited the opposite mechanical effects in patients,
increasing systolic and pulse pressure in the carotids, decreasing intima-media
thickness, and increasing circumferential wall stress even further ( =

↑ ∗
↓↓

).

However, the only statistically significant change in measured physiological parameters
was an increase in stiffness/elastic modulus, corresponding with a nearly significant
decrease in distensibility. Despite conflicts between hypothesis and result, prospective
and randomized administration of celiprolol still successfully and significantly reduced
the incidence of arterial rupture and/or dissection in treated vEDS patients in comparison
with untreated vEDS patients14.
The authors suggest that the effects of β2-adrenoceptor agonism depend on the
sympathetic milieu already present in recipients, which would lead to vasodilation in
17

already hypertensive subjects but to sympathomimetic effects in normotensive subjects,
like the vEDS patients treated here. At the same time, celiprolol, like all β-blockers,
would prevent excessive blood pressure and heart rate spikes, as during exercise34 (or
anxiety), so the authors speculate that celiprolol, rather than reducing global wall stress,
may instead have stabilized hemodynamics14. This is a subtle but crucial distinction, as,
in the context of a two-phase model for elastic arteries, it implies that the treatment
prevented episodic fluctuations of especially high stress. So vEDS may not pose so
much a risk of "fragility" due to baseline weakness but instead confer a vulnerability in
the safety mechanisms designed to deflect the threat of episodic injury.
The clinical endpoints of vEDS patients in the trial validate this distinction–not
only do the untreated patients suffer the episodic and catastrophic vascular complications
already well-characterized for vEDS, some of the treated vEDS patients suffer the same
episodic and catastrophic complications as well. The conclusions of the trial declare that
significantly fewer patients suffer complications under the treatment, but the severe and
mostly unheralded nature of the arterial dissections and ruptures remain the same, even
deadly. Notably, some connection to a precipitating event is mentioned for the one
patient who died under celiprolol treatment, who suffered sudden death with acute chest
pain radiating to the right arm one day after practicing shot put. Otherwise, blinded
experts on a committee reviewing clinical endpoints were unable to discern a patient's
assignment to the treatment or control arm based on the severity of outcome14. One
explanation consistent with these results is the possibility that celiprolol decreased the
risk for discrete injury to arteries in vEDS patients by decreasing the likelihood of
episodes of excessive wall stress, but that celiprolol is ineffective at preventing the
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sequelae of injury once breakthrough injuries occur. The role of sequelae deserves
attention here in lieu of the moderate delay between the minor trauma of shot put
practice and the onset of deadly dissection or rupture, rather than the activity of shot put
itself eliciting sudden death.
Together, the findings from this trial seed skepticism in the assumption that
tissue fragility in vEDS patients results directly from deranged collagen levels at
baseline. Although effects of deranged matrix on biomechanics clearly contribute to
vascular complications, the link is not direct, and manipulating baseline circumferential
wall stress does not cure the disease. Separate proximal events are likely necessary for
the rapid development of arterial pathology and the precipitous failure of biomechanical
strength. Further insight and improvements in therapy may come from exploring the
events between injury and mechanical failure, which likely include aberrant remodeling
of the vasculature and the dysregulation of new collagen synthesis. We predict that
episodic arterial injury unmasks the vulnerability to arterial dissection and/or rupture in
vEDS patients, and that this vulnerability involves the evolution of structural defects in
the media of arteries. We further predict that genetic mutations inhibiting the production
of type III collagen disrupt the normal regulation of vascular remodeling to promote the
occurrence of such structural defects.
In the following chapters, we introduce the concepts of thrombus resolution as a
form of vascular wound healing and the organization of thrombi by resident
myofibroblasts as akin to the formation and remodeling of new matrix within
vascularized granulation tissue. Thus, we hypothesize that injury eliciting the
formation of occlusive thrombi within genetically-vulnerable arteries unmasks
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defective thrombus resolution resulting from impaired production of type III
collagen. This causes deranged remodeling of matrix, persistent inflammation, and
dysregulated behavior by resident myofibroblasts, culminating in persistent
granulation tissue and the development of penetrating neovascular channels that
disrupt the mechanical integrity of the arterial wall. The following research project
will, first, confirm delayed thrombus resolution and persistent neovascularization
following arterial injury in type III collagen-deficient mammals; second, confirm
dysregulated myofibroblast synthesis and organization of a collagenous matrix in the
absence of sufficient type III collagen during remodeling of a fibrin lattice, and finally,
confirm the necessity of dysregulated matrix production and organization by resident
myofibroblasts for the generation of wall defects by impeding myofibroblast
involvement in thrombus resolution and preventing the differential incidence of
neoangiogenesis. In short, we are presenting a novel and paradoxical model of
pathogenesis wherein deficiency of type III collagen leads to a fibroproliferative
vascular wound healing program that episodically leads to an increased burden of
vascular wall defects, rather than the baseline "tissue fragility" in the tension
generated by organ wall matrix more commonly assumed to be the etiology of
complications in vEDS patients.
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Chapter 2: Injury to Carotid Arteries in Type III Collagen-Deficient Mice
Unmasks Delayed Thrombus Resolution and Persistent Neoangiogenesis
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Introduction
Correlation of the Clinical and Cellular Phenotypes in Patients and Mice with
COL3A1/Col3a1 Mutations
Most vEDS patients harbor missense or exon skip mutations in COL3A1, leading
to a dominant negative effect on the cellular secretion of type III collagen that inhibits its
accumulation and consequently alters the otherwise uniform diameters of type I collagen
fibrils9. With the creation of a type III collagen knockout mouse by targeted deletion of
the promoter and first exon of the Col3a1 gene15, other researchers confirmed similarly

Figure 2.1. Transmission electron microscopic analyses of aorta and skin from
wild-type and mutant mice. (C) Cross section of the collagen fibrils in the
adventitia of wild-type aorta. Arrows point to individual fibrils. The diameter of the
collagen fibrils is smaller and relatively uniform compared with the fibrils (arrows)
of mutant aorta in D. (E) Skin section of wild-type mouse. The collagen fibrils
(arrows) are uniform in diameter. (F) Skin section of mutant mouse. The collagen
fibrils are often thicker (arrows) or thinner (arrowheads) than control fibrils and are
not uniform in diameter. Right, Comparison of the diameters of collagen fibrils in
the adventitia. A 2µm x 2µm area in the adventitia was randomly chosen, and all the
fibrils were measured for their diameters and counted. Reprinted with permission
from the National Academy of Sciences of the United States of America [Type III
collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular
development. Liu X, Wu H, Byrne M, et al. Proceedings of the National Academy
of Sciences. 1997].
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variable diameters and a higher mean diameter in collagen fibers from the tissues of
Col3a1-/- mice. In fact, the number of fibrils in cross-sections of the adventitia was
around one-third the number in normal mice, but the average diameter was twice that of
controls, roughly computing a 33% greater cross-sectional area occupied by collagen
fibrils in Col3a1-/- tissues (Figure 2.1). Adult Col3a1-/- mice appeared grossly
indistinguishable from littermates, except for a 15% decrease in body size, but they also
developed spontaneous skin lesions and organ rupture, most often dissection and rupture
of large elastic arteries, limiting their life-span to 20% of that in their wild-type
littermates. Interestingly, no obvious sentinel characteristics of collagen deficiency were
observable by histochemical analysis (Masson's trichrome stain) of non-dissected
Col3a1-/- arteries compared with controls, but electron microscopy identified a subtle
deficiency of collagen fibrils in the small spaces between smooth muscle cells and
elastin fibers in the media15.
However, the creators reported only a rare 5% survival rate of null mice to
weaning age, with the majority of deaths occurring perinatally within 2 days of birth15.
Only one similar young vEDS patient who possessed two null alleles has been reported,
and she succumbed very prematurely to the catastrophic complications of vEDS at 11
years of age35. Thus, the Col3a1-/- mouse does not provide a tractable or entirely
translatable model for the study of type III collagen deficiency in adult mammalian
tissues. In fact, a group of collaborators maintaining a colony of these knockout mice at
the National Institutes of Health Institute of Aging, Wilfried Briest and Mark Talan,
claimed to have never observed Col3a1-/- offspring despite appropriate breeding
schemes.
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Unfortunately, the creators of the type III collagen-deficient mouse model
neglected to report very extensively on the haploinsufficient Col3a1+/- mouse, only
mentioning that collagen extracts from the skin of heterozygous mice contain ~50% of
normal type III collagen (α1(III)) levels. Of note, they also report electrophoresis
evidence that type I collagen levels in skin from mutant mice (as separated into α1(I) and
α2(I) monomers on the gel) may exceed those in wild-type littermates (Figure 2.2),
although they explain this as underloading of the gel. Otherwise, the manuscript
concludes that Col3a1+/- mice are "phenotypically normal15," and this presumably
includes their life span.

Figure 2.2. Collagens from tails and skin of wild-type mice and type III collagen
mutants. Collagens were resolved by SDS/PAGE and stained with Coomassie blue.
The type III collagen molecule consists of three α1(III) chains. The β1,1 and β1,2
dimers and the α1(I) and α2(I) chains are all from type I collagen and serve as internal
controls for the loading. Reprinted with permission from the National Academy of
Sciences of the United States of America [Type III collagen is crucial for collagen I
fibrillogenesis and for normal cardiovascular development. Liu X, Wu H, Byrne M, et
al. Proceedings of the National Academy of Sciences. 1997].
Ironically, these Col3a1+/- mice may actually pose a more attractive model for
precisely investigating the role of injury in precipitating pathology, since the animals do
not spontaneously die in the absence of manipulation. Furthermore, experiments
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investigating vascular mechanics in Col3a1+/- arteries determined that those explanted in
middle age (14 months) withstand rupture even under extreme supraphysiologic
pressures (>800mgHg) comparably to explanted wild
wild-type arteries and that significant
differences in mechanical strength as a function of Col3a1 gene dose only emerge in old
age (21 months) and again only under extreme pressures (>700mmHg), providing strong
evidence against the idea that type III collagen
collagen-deficient tissues
ssues are inherently weak or
fragile at baseline36 (Figure 2.3). This normal phenotype (and apparently normal

Figure 2.3. The maximum pressure in the abdominal aorta was measured in 1414 and
21-month old wild-type
type (+/+) and heterozygous (+/
(+/-)) mice. Number of experiments
show in parentheses. Reprinted with permission from SAGE Publications [The
haploinsufficient Col3a1 mouse as a model for vascular Ehlers
Ehlers-Danlos
Danlos syndrome.
Cooper TK, Zhong Q, Krawczyk, et al. Veterinary Pathology. 2010].
mechanical strength) is a stark contrast to reports of human vEDS patients with
haploinsufficiency of type III collagen due to heterozygous frameshift mutations causing
premature
emature termination codons and nonsense-mediated
mediated decay of the message.
message These
haploinsufficient vEDS patients suffer arterial aneurysms, dissections, and/or
or rupture,
with precipitous clinical courses at premature ages virtually identical in severity to those
tho
described for patients with dominant negative missense mutations. Strikingly, cell
culture experiments testing the secretion of type III procollagen by explanted patient
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fibroblasts failed in three of four cases to demonstrate any diminished production37
(Figure 2.4).

Figure 2.4. SDS/PAGE of radiolabeled procollagens from medium and fibroblast
cell layer, analyzed under reducing conditions, from a control cell line (lanes C) and
cell strains from four individuals with EDS type IV (P1-P4). In cells from P1 the
dimunition in the amount of pro- α1(III) is evident, but it is not clear in the other
three individuals. FN = fibronectin. Reprinted with permission from Elsevier
[Haploinsufficiency for one COL3A1 allele of type III procollagen results in a
phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos
syndrome type IV. Schwarze U, Schievink WI, Petty E, et al. American Journal of
Human Genetics. 2001].
However, the researchers identifying these patients later widened their
investigation to include family members and discovered that many relatives carrying
identical mutations had survived beyond 50 years of age with no life-threatening
complications. From this larger cohort of type III collagen haploinsufficient patients,
they determined that these genotypes conferred a milder phenotype characterized by
extended life spans, delayed age of first complication, and a complete predominance of
lethal complications in the vascular system over the gastrointestinal or female
reproductive systems38. Thus, the severity of complications affecting the index patients
from the first report likely involved exposure to additional risk factors, possibly vascular
injuries, that did not occur in their less affected family members, since their identical
genotypes alone cannot explain the susceptibility to mechanical failure. At the same
time, the ability of cells from these index patients to produce normal levels of
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extracelluar type III collagen at baseline was intact. It is plausible that such patients
would be more vulnerable to pathological events in which the rate of type III collagen
production, rather than absolute production, was more crucial to outcome.

Stroke, Spontaneous Cervical Artery Dissection, and Precipitating Injury
Despite suggestive episodic and catastrophic clinical courses in vEDS patients,
injurious events within the vasculature remain elusive and likely subtle. Fortunately, the
development of complications in another cohort of patients bearing significant clinical
overlap with vEDS are very strongly associated with vascular injury. Between 10 and
25% of strokes in patients younger than 45 years of age result from "spontaneous"
dissection in one of the major cervical arteries (the carotid or vertebral arteries)39.
Multiple observations suggest the presence of constitutive arteriopathies in many of
these patients: increased risk for recurrence with youth at first occurrence; increased risk
for dissection of other arteries; familial cases of cervical artery dissection; association of
dissection with familial intracranial aneurysms; and 15% co-occurrence of fibromuscular
dysplasia, arterial redundancies, or abnormal distensibility on angiography40. However,
identifiable single-gene mutations occur only rarely. Despite the fact that spontaneous
cervical artery dissection (sCAD) is a common presentation for arterial complication in
vEDS30,41, vEDS patients only constitute 2% of sCAD patients. Patients with Marfan
syndrome, caused by mutations in FBN1 affecting the integrity of microfibrils
connecting smooth muscle cells to elastic laminae in the arterial matrix, are responsible
for only 0.6-0.9% of sCAD cases. Patients with Loeys-Dietz syndrome (a syndrome
caused by mutations in TGFBR1 or TGFBR2 with two distinct clinical subtypes
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overlapping with both Marfan syndrome and vEDS) are responsible for only rare cases
of sCAD42.
Nonetheless, in the non-syndromic population, the risk for dissection of arteries
in the neck greatly exceeds the risk in arteries of similar size elsewhere in the body, such
as the coronary or renal arteries, and clinician scientists have suggested an explanation
arising from greatly increased mobility of cervical arteries and particular vulnerability to
trauma39. Although severe and direct trauma to the neck can precipitate dissection, as
following motor vehicle accidents or sports injuries39,43, patients suffering "spontaneous"
dissections may report histories of minor or trivial trauma involving extension or torsion
of the neck, such as coughing, vomiting, sneezing, painting a ceiling, or lying the head
back for a dental exam or over a sink at a salon39,44. From our own clinical experience,
the most colorful incidences of similar trauma preceding dissections involved scuba
diving, lifting a chair overhead at a Jewish wedding, and performing the "extreme" yoga
poses of the P90X exercise regimen (Table 2.1).

Table 2.1. Trivial causes of carotid dissection. Reprinted with permission from the
Massachusetts Medical Society [Bottoms-up dissection. Trosch RM, Hasbani M, Brass
LM. New England Journal of Medicine. 1989].
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Figure 2.5. Pathological findings in a 37-year old woman with a dissection of the
internal carotid artery. Photomicrographs of the right extracranial internal carotid
artery (Panels A, B, and C) show a dissection within the outer layers of the tunica
media, resulting in stenosis of the arterial lumen (L). The rectangles outlined in blue on
the left indicate the sites of the photomicrographs. The intramural hemorrhage
(asterisk) extends almost entirely around the artery (Panel A, van Gieson's stain, x4).
Higher-power views of the internal carotid at the point of dissection show
fragmentation of elastic tissue (Panel B, van Gieson's stain, x25), with the
accumulation of pale ground-glass substance in the tunica media, indicated by the bluestaining mucopolysaccharides (Panel C, Alcian blue, x25). These changes are
consistent with the diagnosis of cystic medial necrosis. Reprinted with permission
from the Massachusetts Medical Society [Spontaneous dissection of the carotid and
vertebral arteries. Schievink WI. New England Journal of Medicine. 2001].
Dissections originate from a breach of the arterial wall integrity and are less
severe than–though increasing the risk for–a complete rupture of all three layers. Instead
of frank hemorrhage, dissection involves the entry of pressurized blood into a false
lumen within one of the layers of the artery, most often the media, or between layers,
like between the media and adventitia (Figure 2.5). Many speculate that blood enters
through an intimal tear, which makes sense with the stretching nature of neck injuries.
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Figure 2.6. Findings on magnetic resonance imaging and angiography in a in a
37-year old woman with a dissection of the internal carotid artery. On T1weighted magnetic resonance imaging, an axial view (upper left) and a sagittal view
(upper right) show a subacute intramural hematoma in the wall of the right internal
carotid artery (arrows). On carotid angiography, a frontal view (lower left) and a
lateral view (lower right) show a corresponding long segment of high-grade stenosis
extending from about 2cm distal to the carotid bulb to the base of the skull (arrows).
Reprinted with permission from the Massachusetts Medical Society [Spontaneous
dissection of the carotid and vertebral arteries. Schievink WI. New England Journal
ofHowever,
Medicine.these
2001].
tears or any other communication between false and true lumina are
notoriously difficult to locate on close inspection of postmortem or surgical specimens,
providing evidence of primary intramural hematomas in at least some cases.
Displacement of the wall impinges on flow in the true lumen, which can cause widely
distributed ischemia downstream of the occlusion and ~10% of the time create a "candle
flame" or "string sign" on angiography39 (Figure 2.6), but more often promotes arterial
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thrombosis through altered flow dynamics and the discharge of emboli that induce
ischemic strokes located remotely from the dissection45.
The onset of dissection can present as one-sided neck pain with or without
ipsilateral headache, but the onset of neurological deficits and stroke occurs after a delay
of hours to days following internal carotid dissection and two weeks following vertebral
artery dissection39. At the same time, the onset of pain may itself follow a delay of
hours, days, and weeks after minor or blunt traumas46,47 or even after respiratory tract or
varicella infection48,49, obscuring a precise cause-to-effect link. The classic but
contentious association between chiropractic manipulation and stroke, with 1 in 20,000
manipulations preceding stroke and one-quarter of those affected harboring a
generalized connective tissue disorder, is consistent with a role for injury, although it
belies the confusing temporal relationship between injury and symptoms. Patients with
neck pain (of note, the posterolateral pain of vertebral artery dissection mimics
musculoskeletal pain) often seek chiropractic relief39, but in our experience in a medical
genetics clinic, patients with generalized connective tissue disorders often suffer chronic
pain and may seek chiropractic manipulation on multiple occasions. Regardless, it is
possible that covert events pathologically altering arterial structure in response to
repeated subacute injury could lower the threshold for acute dissection in response to
any one particular episode of injury.

Carotid Ligation: A Surgical Model for Vascular Injury
Ligation of the carotid artery in mice was developed as a reproducible model for
vascular injury and the robust development of neointimal lesions, which resemble
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pathological intraluminal lesions such as fi
fibromuscular caps in atherosclerosis or
restenotic scarring following
wing endovascular interventions
interventions. Though smaller than pigs or
rats used in similar studies, mice allow investigators to assess genetic influences on
vascular remodeling50. Neointimal lesions are a generic response
onse to a wide variety of
arterial insults, analogous to cutaneous scars in the skin or gliosis in the brain. They are
characterized by the new and abno
abnormal appearance of hyperplastic vascular smooth
muscle cells and/or myofibroblasts (fibromuscular cells
cells,, more generally) and the new
fibrotic matrix they synthesize within the intima, i.e., between the endothelial cells lining
the lumen and the internal elastic lamina51. The apparent inward expansion of these
lesions occludes the lumen of ligated vessels 52,53. Formation of neointima is of interest
to this project as a scenario of vascular remodeling occurring exclusively in response to
local injury, and it involves substantial production and organization of new extracellular
matrix.

Figure 2.7. Illustration of the carotid ligation procedure. The left common carotid
artery is dissected away from fascial layers in the neck, just lateral to the trachea, and
silk suture is used to tie off the artery just proximal to the bifurcation between the
internal and external carotid arteries. This interrupts net forward flow from the heart,
heart
although the vessel remains pressurized proximally at physiologic blood pressures.
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The procedure involves dissection of the left common carotid artery away from
the carotid sheath and vagus nerve in the neck and permanent ligation with silk suture
just proximal to the bifurcation forming the left internal and external carotid arteries
(Figure 2.7). The result is the abolition of net forward flow through a section of elastic
artery that arises as a branch off the aorta but contains no other branches of its own,
while pulsatile pressures remain intact and active until sacrifice50. Most animals survive
the procedure without symptoms of stroke, due to relatively robust collateral cerebral
circulation in rodents54,55, and continue normal behavior. In our experience, a brief
period of weight loss and recovery occurs in the first 3-7 post-operative days related to
neck pain and decreased motivation for eating and drinking. Animals are supported
through this period with analgesics and limited subcutaneous administration of fluids.
Alterations in blood flow and shear stress on the walls of arteries can
independently induce adaptive vascular remodeling. A classic example is the "Glagov
phenomenon,” where increased flow velocity and shear stress, in Glagov's case due to
narrowing of a coronary artery lumen by atherosclerotic plaque buildup but also through
exogenous narrowing by partial ligation of the carotid, appears to direct enlargement of
the arterial media diameter56,57. On the other hand, decreases in flow velocity and shear
stress promote narrower vessels, either by restriction of medial enlargement58 or by
driving orientation and hyperplasia of occlusive fibromuscular cells in the neointima59.
The stereotyped development of atherosclerotic lesions at certain anatomical locations,
namely bifurcations, branch ostia (openings), and curvatures, has long been associated
with vascular geometries susceptible to decreased flow and shear stress60.
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However, decreased flow, as in the carotid ligation injury model, also promotes
formation of thrombus through the accumulation of platelets and coagulation factors,
expediting the kinetics of platelet activation and fibrin polymerization61. Investigations
of early events in arteries following carotid ligation (e.g., one week post-operatively)
reveal extensive platelet-rich and fibrin-rich thrombi in the lumen62. Thus, an intense
interaction between thrombus formation/resolution and neointimal hyperplasia in the
carotid ligation model of injury captures this element of the pathophysiology of diseases
like atherosclerosis63 or restenosis following endovascular intervention64,65, which
involve localized wall injury, flow disruption, and thrombogenesis. In vEDS and sCAD
patients, risk factors for thrombosis could include decreased flow but may also include
minor tears in the wall, as from stretch or from hypertensive episodes that expose the
"hemostatic envelope" of tissue factor protein embedded in the media and adventitia,
which quickly activates the coagulation cascade66.
The initial descriptions of neointimal formation in arteries following ligation
indeed mention the histological appearance of organizing thrombus in injured vessels but
neglect to link the phenomenon with intimal hyperplasia, since most arteries contain no
evidence of thrombus at the later time points of investigation53. Other researchers
ligating veins in order to study thrombus organization noted occasional continuity
between resolving thrombi and "invading" intimal hyperplasia67. However, the strongest
evidence of thrombus resolution necessarily preceding neointima formation emerges
from studies exploiting carotid injury in animals genetically deficient in fibrinolytic
enzymes. These studies found that inhibiting resolution of thrombus prevents the
development of neointima by late time points (e.g., three weeks post-operatively)68.
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Although these studies exogenously applied ferric chloride to arteries to injure them,
other researchers performing carotid ligation discovered that depleting animals of fibrin
or platelets also prevents development of neointima by late time points62.

Thrombus Resolution, Wound Healing, and New Matrix Production
Thrombus organization and resolution remarkably resembles wound healing,
where polymerized fibrin at the site of injury forms a nidus for recruitment of
inflammatory cells, followed by a wave of migrating fibromuscular cells to remodel and
contract the provisional fibrin matrix into a collagenous scar62,69,70. We suspect that
defective wound healing in vEDS patients, which necessitates the new synthesis of both
type III and type I collagen, may comprise not only dysfunctional responses to cutaneous
injury but also dysfunctional responses to arterial injury. Familiarity with the
orchestrated processes of wound healing and scar formation would guide a more
purposeful investigation of processes driving thrombus resolution and neointima
formation.
Wound healing progresses through three overlapping phases: the inflammatory
phase extending through post-injury days 3 to 7, the tissue formation/proliferative phase
extending through day 14, and the more indefinite tissue remodeling/contraction
phase19,28. The early inflammatory phase entails the recruitment, activation, and
infiltration of circulating inflammatory cells into fibrin clots via chemoattractants
released by platelet degranulation and/or coagulation/complement activation. In this
phase, initial sources of the pro-fibrotic cytokine transforming growth factor-β1 (TGFβ1) include both platelets and activated macrophages, although depletion of platelets
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permits normal wound healing while depletion of macrophages does not, suggesting that
the sustained, amplified signaling by macrophages critically drives downstream repair
activity by resident cells19,28,71. Although not acknowledging thrombus resolution as
such, vascular biologists also describe very early platelet and inflammatory production
of TGF-β1, as well as enzymatic release of its active form from the local matrix, that is
necessary for later neointimal thickening following vascular injury72.
The tissue formation or proliferative phase begins with the activation,
proliferation, and migration of previously sedentary cells into the wound margin or
thrombus. TGF-β1 acts both as chemotactic agent and mitogen for skin fibroblasts71,
initiating their transformation into myofibroblasts with a comparatively striking capacity
for matrix synthesis and cellular contractility73. The effect of TGF-β1 on vascular
smooth muscle cells is less clear from the cell culture literature, where TGF-β1 can
stimulate or inhibit proliferation based on cell density or dose72. Following in vivo
injury by balloon angioplasty, however, infusion of recombinant TGF-β1 stimulated
proliferation of cells in the neointima but not cells in the media, suggesting that the cells
residing in the neointima behave more like myofibroblasts than smooth muscle cells74.
Rapid synthesis of new matrix and angiogenesis necessary to supply nutrients for
high metabolic activity in this middle phase earn the name of "granulation tissue" for the
emerging stroma, as gross inspection reveals a red granularity from dense capillaries28.
One of the first associations of TGF-β1with wound healing arose from its subcutaneous
injection into neonatal mice, which was sufficient to induce new granulation tissue
including neovascularization and fibrosis75. Formation of granulation tissue could prove
to be a critical juncture of events in wound healing for type III collagen-deficient vEDS
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patients and mice, as de novo conversion of provisional fibrin matrix into collagenous
matrix in the skin heavily involves the new secretion of both type I and type III
collagen73,76, while a similar burst of gene expression for type I and type III collagen
synthesis, as measured by transcription of Col1a2 and Col3a1, coincides with neointimal
formation following intraluminal injury in rats74.
The extent of neovascularization positively correlates with the rate of thrombus
resolution in experimental models of deep vein thrombosis69,70, suggesting that
neovascularization is essential for recanalizing the lumen of occluded vessels. In
thrombus resolution, neovascularization appears both as endothelial cell-lined vascular
channels continuous with lumen that extend axially through the body of the thrombus
and as endothelial cell lining at the circumferential thrombus surface that invaginates
into perforating clefts, sometimes observed in continuity with inward extensions of the
adventitial vasa vasorum70 (Figure 2.8). In diseases involving arterial thrombosis,
however, neovascularization is often regarded as a problem. Fragile neovessels limited
to sites of injury extend from the vasa vasorum through the media and into intimal
plaque, where they are thought to increase the risk for intramural hemorrhage and plaque
instability in atherosclerosis77. Following intravascular stenting, the incidence of
neovessels corresponds with neointimal thickness, and investigators predicted later
strategies of reducing stenotic neointimal growth by the use of agents to prevent
neovascularization78.
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Figure 2.8. Transverse section through a human vein containing organizing
thrombus stained by MSB. Erythrocytes yellow, fibrin and smooth muscle cells red,
and collagen blue. Note areas of neovascularization (arrows) appearing at the
thrombus wall interface and within the body of the thormbus. Reprinted with
permission from Schattauer GmbH [The role of neovascularisation in the resolution of
venous thrombus. Modarai B, Burnand KG, Humphries J, et al. Thrombosis and
Haemostasis. 2005].
The final stage of wound healing, the remodeling and contraction phase, involves
the contraction of volume of granulation tissue through a compaction and reorganization
of the newly synthesized matrix, as well as a drop in the cellularity and vascularity of the
resulting scar28,79. This phase will be discussed in much more depth in Chapter 3.
For the first aim of this project, we sought to confirm defective vascular wound
healing in type III collagen-deficient mice. We induced vascular injury in type III
collagen-deficient mice through carotid ligation and followed the development and
subsequent resolution of thrombus alongside the development of neointimal hyperplasia
at various post-operative timepoints. From this we discovered delayed thrombus
resolution in Col3a1+/- mice in association with a significantly higher incidence of
neovascularization penetrating into media. Overexuberant neovascularization began in
the proliferative and tissue formation phase of vascular wound healing, which was also
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associated with excessive burdens of tissue macrophages and proliferating fibromuscular
cells in resolving thrombi. Neovessels persisted over time in type III collagen-deficient
animals, in contrast to wild-type littermates, abnormally appearing even in arterial
segments containing mature neointimal lesions. We suggest that the abnormal
persistence of these neovessels and dysfunctional vascular wound healing contributes to
the risk for dissection and/or rupture of arteries in patients with vEDS and sCAD.

Methods
Mouse Husbandry, Breeding, and Genotyping
Cryopreserved embryos derived from the Col3a1 knockout on BALB/c
background mouse line developed by Liu, et al.15 were purchased and transferred into
surrogate BALB/c mothers for the recovery of two litters of Col3a1+/+ and Col3a1+/adult mice by Jackson Laboratories (Bar Harbor, ME). Adults were subsequently mated
in-house in Col3a1+/+ x Col3a1+/- (wild-type crossed with heterozygote) pairs for a
breeding scheme to produce litters with Mendelian ratios of ~50% Col3a1l+/+ and ~50%
Col3a1+/- offspring. No differences in size, genotype ratios, or number of litters were
obvious in regards to the genotype of mated females, nor were any differences noted in
the ability of mothers to nurse pups to weaning age. All animals were housed and
maintained in the Center for Laboratory Animal Medicine and Care at the University of
Texas Medical School at Houston according to standards set by the NIH Guide for the
Care and Use of Laboratory Animals and the institutional Animal Welfare Committee.
Genotyping of weanlings was performed on DNA extracted from ear pieces and
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amplified by a modified PCR protocol using primers for Col3a1 exon/intron 1 and the
Neo cassette knockout allele designed by Stevenson, et al.80.

Carotid Ligation Injury
Ligation of the left common carotid artery was surgically performed on animals
weighing between 27 and 33g and aged between 22 and 24 weeks (unless otherwise
stated), corresponding to the tail end of the mature adulthood phase in mice (age 3 to 6
months) through which animals have completed development but are not yet influenced
by senescence, according to estimation from the gerontology laboratory of David
Harrison, PhD at Jackson Laboratories. This phase approximates the span of 20 to 30
years of age in humans (http://research.jax.org/faculty/harrison/ger1vLifespan1.html), in
which the risk of fatal complications in vEDS patients rapidly increases10. However, this
phase in the Col3a1 knockout mouse model is not associated with any differences
between Col3a1+/+ and Col3a1+/- mice in risk for complication or survival15.
Anesthesia was induced with 4% isoflurane inhaled in an induction chamber and
maintained by 2-2.5% isoflurane inhaled through a nosecone. The surgical procedure
involved preemptive analgesia with subcutaneous ketoprofen (5 mg/kg), a midline
incision in the neck, dissection of the left common carotid artery away from the carotid
sheath and vagus nerve, and ligation of the artery with 5-0 silk suture just proximal to
the bifurcation of the internal and external carotid arteries50. Wounds were irrigated
with sterile saline and closed by 2-3 interrupted stitches with absorbable 5-0 suture.
Approximately 20% of animals either recovered from the procedure with
symptoms of stroke, developed symptoms of stroke over the first 7 post-operative days,
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or failed to maintain less than 20% loss in body weight and were sacrificed. Risk of
stroke following carotid ligation in mice from a BALB/c background corresponds to
strain-specific relative insufficiency in collateral cerebral flow55. Nonetheless,
neurologically intact animals were supported post-operatively for 2 days with
subcutaneous ketoprofen (2-5 mg/kg) twice a day for analgesia and for 7 days following
daily weighing with subcutaneous 0.5-1 ml injections of lactated Ringer's solution as
needed for >10% drops in body weight. No unexpected deaths occurred after postoperative day 7 (POD7), and animals were sacrificed on POD7, POD14, and POD21 for
the various experiments described below.

qPCR Analysis of Col3a1 Expression in Injured Arteries
For extraction of cellular RNA from whole tissues, thoracotomy at sacrifice was
followed by immediate dissection and harvest of fresh carotid arteries. To measure
baseline expression of Col3a1 in normal tissues, we harvested the lengths of normal left
and right common carotid arteries (LCAs and RCAs) from 7-month-old mice, both
Col3a1+/+ and Col3a1+/-, which had not undergone carotid ligation (N = 3 Col3a1+/+, 3
Col3a1+/-). Each harvested LCA extended from the ligature proximally to the
branchpoint from the aorta, and each RCA extended from just proximal to its bifurcation
down to the branchpoint from the brachiocephalic artery. To then measure the normal
effects on Col3a1 expression elicited by injury, we also harvested the injured LCAs and
uninjured RCAs from 7-month-old Col3a1+/+ mice (N = 5) on POD7 following carotid
ligation.
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Fresh arteries were quickly dipped in sterile RNase-free water to wash away
excess blood and each immediately immersed in 1ml TRI reagent (Sigma, Saint Louis,
MO) and frozen at -80°C. After confirmation of genotypes, separate artery samples
were quickly thawed and tissues and TRI solvent pooled among experimental groups
(normal left and right Col3a1+/+ carotids together, normal left and right Col3a1+/carotids together, injured post-operative Col3a1+/+ LCAs together, and uninjured postoperative Col3a1+/+ RCAs together) for homogenization within the same round-bottom
tube using an electric Polytron homogenizer (Thomas Scientific) for at least one minute
to disrupt connective tissue and lyse resident cells. Further RNA extraction was
performed according to manufacturer's instructions, resulting in the dissolution of
extracted RNA in sterile RNase-free water.
Resulting RNA concentration was measured by absorbance at 260nm using a
NanoDrop ND-1000 spectrophotometer, and only samples with RNA purity determined
by A260/A280 ≥ 1.8 were used. Reverse transcription of cDNA was performed according
to instructions from a High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems). Quantitative PCR was performed using pre-designed TaqMan assays for
mouse Col3a1 (the target gene) and Gapdh (the internal control gene) on an ABI Prism
7000 Sequence Detection System (Applied Biosystems). Quantification of normalized
gene expression related Col3a1 message levels from various post-injury samples to
normalized baseline levels in an equivalent mass of RNA derived from uninjured carotid
arteries according to the Comparative CT method81. As we suspected that separate
biological samples would be insufficient in size to yield RNA concentrations necessary
for qPCR, we pooled similar samples during homogenization to generate only one
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cDNA sample per experimental condition. Thus, we did not perform PCR on one cDNA
sample per tissue within each experimental condition, and statistical analysis accounting
for standard deviation between biological replicates by Student's t test was not possible.
However, reported results still represent Col3a1 message levels "averaged" among
biological replicates by means of chemical diffusion rather than by statistical means.
Error bars represent assay precision, i.e., standard deviation between fold-changes
derived from triplicate PCR reactions performed on each cDNA sample.

Histological Analysis: Morphology
For histological analysis of arteries at POD7 (N = 5 Col3a1+/+, 4 Col3a1+/-),
POD14 (N = 7 Col3a1+/+, 4 Col3a1+/-), and POD21 (N = 8 Col3a1+/+, 9 Col3a1+/-),
thoracotomy at sacrifice was followed by puncture of left ventricles with a 22-guage
needle. Right atria were incised to allow outflow of perfusate, and animals were
perfused at <20 ml/min with phosphate-buffered saline until exsanguination was
confirmed by blanching of the liver. We then perfused the mice with 10 ml of 4%
paraformaldehyde or 10% buffered formalin at the same rate to initially fix arteries in
their native geometry. We harvested the lengths of injured left common carotids and
uninjured right common carotids as above.
Harvested arteries were further fixed by submersion in 4% paraformaldehyde or
10% buffered formalin overnight and routinely processed by automated machine. After
processing, the arteries were chilled and cut twice with a scalpel: first just proximal to
the ligature to remove the suture and preserve as much of the distal length as possible
and secondly to bisect the artery into two pieces. With careful attention to maintaining
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orientation, the pieces were each embedded into paraffin vertically in the same block
with the distal tips downwards to allow for axial cross-section. Serial sectioning was
performed through the entire block, collecting three 4 µm-thick sections per slide, with
almost all sections each containing samples from both halves of tissue, until all of the
original length of the artery had been collected in sequence. Every tenth slide from this
sequence was then subjected to routine automated hematoxylin and eosin (H&E)
staining and a representative section microscopically photographed at 20x and 40x
power. This set of systematically sampled images allowed us to reconstruct an index of
arterial histology as it varied along the full axial length of the injured tissues. Left
common carotid arteries from each mouse supplied approximately 90 to 120 slides,
corresponding to 18 to 24 index images per artery. All images are presented at 40x,
unless otherwise stated, and scale bars represent 200µm. For 100x images, scale bars
represent 50 µm.

Statistical Analysis: Incidence of Unresolved Thrombus and Neovessels
The cell-dependent resolution of intraluminal thrombi progresses like a migrating
wave in the direction of blood flow69, so that the maturity of wound healing represented
by any given tissue section varies extensively as a function of non-uniform, especially
localized phenomena related to the longitudinal location of the segment within the
artery. Thus, arterial segments photographed in cross-section at a systematic distance
from each other, even those from the same artery, each present highly unique
information. The aggregated information resembles discrete, independent biological
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events occurring at certain frequencies much more than it resembles dependent,
clustered technical estimations of a continuous parameter.
As such, we treated each index H&E-stained slide as an independent sample and
judged whether the individual arterial segment contained unresolved, occlusive
thrombus or not and whether the individual segment contained circumscribed neovessels
penetrating the arterial media or not. Multiple observers were blinded to the genotype of
the arterial segments, and positive and negative ratings for all arterial segments under an
experimental condition were decided independently by the same observers and agreed
upon consistently, recorded, and pooled by genotype, Col3a1+/+ or Col3a1+/-. Results
were entered into a 2x2 contingency table, and the actual frequencies of events were
compared with expected frequencies predicted by the hypergeometric distribution by
determining an exact probability using the Fisher's exact test. Significantly low p-values
(p < .05) were interpreted to reject the null hypothesis that frequency of occlusive
thrombus or of neovessels occurred independently of the genotype of the arterial
segment.

Histological and Statistical Analysis: Immunohistochemistry, Macrophage Burden, and
Prevalence of Proliferating Myofibroblasts in Unresolved Thrombi
Records of indexed H&E- stained arterial segments as obtained above provided
the relative locations of segments containing occlusive thrombi. Unstained slides
neighboring each of the thrombus-positive slides were subjected to
immunohistochemical probes to determine the local burden of macrophages and the
local prevalence of actively proliferating myofibroblasts within the resident thrombi.
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Thus, each original thrombus-positive slide corresponded to a local slide measuring the
number of Mac2-positive cells present and a second local slide measuring the number of
phosphorylated histone H3 (pH3)-positive nuclei present. Unstained slides neighboring
neovessel-positive index slides were similarly subjected to probes for the presence of
CD31, a marker for immature endothelial cells and/or circulating endothelial cell
precursors82.
Unstained sections were deparaffinized and rehydrated by immersion in xylenes
followed by immersion in a graded alcohol series. Most tissues were then subjected to
heat-induced epitope retrieval (HIER citrate pH 6.0) and were blocked for 1h at room
temperature with diluent. For imaging of resident macrophages, tissues were incubated
for 1h at room temperature with rat anti-mouse Mac2 primary antibodies (Cedarlane,
Burlington, NC). For imaging of mitotic nuclei, tissues were incubated overnight at 4˚C
with rabbit anti-mouse pH3 primary antibodies (Millipore, Billerica, MA). To visualize
neovessels, antigens were first retrieved with EDTA digestion (pH 8.0) instead of HIER,
blocked, and incubated overnight at 4˚C with rat anti-mouse CD31 primary antibodies
for formalin-fixed paraffin-embedded tissues (Dianova, Hamburg, Germany).
Tissues were then washed with phosphate-buffered saline, incubated for 1h with
the appropriate biotinylated secondary antibodes, and primed with peroxidaseconjugated avidin/biotin complexes (Vectastain ABC-AP Kit, Vector Laboratories,
Burlingame, CA). Peroxidase activity was imaged by the developing brown precipitate
following immersion of the tissues in a solution of 3,3'-diaminobenzidine (DAB)
chromogen (Dako, Glostrup, Denmark). Slides were counterstained with hematoxylin,
methyl green, or a combination of methyl green and alcian blue.
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As only slides with occlusive thrombi were sampled for prevalence of
macrophages or proliferative cells, and as slides reflect local phenomena, it was
appropriate to count the number of positive cells or nuclei from each of the relatively
independent slides and determine a mean±SD from the pooled thrombus-positive slides
corresponding to each genotype, Col3a1+/+ or Col3a1+/-. Significant differences
between the means (p < .05) were determined by Student's t-test.

Results
Injury by carotid ligation induces substantial upregulation of Col3a1 expression.
The common carotid arteries from uninjured Col3a1+/+ and Col3a1+/- mice at 7
months of age were pooled and RNA harvested to assess baseline Col3a1 expression in
adult arteries. Transcript levels in Col3a1+/- arteries were lower than in Col3a1+/+
arteries, at 68.6±0.12% of those in normal arteries (Figure 2.9A). To determine whether
Col3a1 expression increases following acute arterial injury, we harvested both left and
right common carotid arteries 7 days after ligation of the left common carotid in 7
months-old wild-type mice. In comparison to baseline levels in normal adult carotids,
ligation of the left common carotid arteries directly induces a 34.5-fold upregulation
(34.5±10.6) in Col3a1 expression (Figure 2.9B). Interestingly, ligation of the left
common carotids also induced a 6.74-fold upregulation (6.74±1.22) of Col3a1 message
levels in the unligated right common carotids (Figure 2.9B), presumably as a result of
increased, redirected cerebral blood flow through these arteries.
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Figure 2.9. Expression of Col3a1 at baseline and following arterial injury by
carotid ligation. (A) Col3a1 expression in heterozygous carotid arteries is 68.6±0.12%
of that detected in wild-type
type carotids. ((B) Relative to the baseline Col3a1 expression in
uninjured arteries as determine
determined in A,, expression following ligation injury to left
common carotids increases 34.5±10.6
34.5±10.6-fold.. At the same time, injury to the left common
carotid also increases expression in the uninjured right common carotid by 6.74±1.226.74±1.22
fold.
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Injury by carotid ligation reveals significantly higher burden of unresolved thrombi in
Col3a1+/- vs. Col3a1+/+ arteries after 21 days.

Figure 2.10. Morphology of arterial responses to carotid ligation by 21 postoperative days. (A and B) Representative sections (40x) showing variation of
morphology along the arterial axis from the distal segments (left) down to proximal
segments (right). Wild-type arteries display limited fibronoid thrombus with mostly
patent arteries except for areas of neointimal thickening located remotely from the site
of ligature. Mutant arteries contain significantly higher incidence of occlusive thrombi
that are densely populated by myofibroblasts. Note penetrating endothelial cell-lined
vascular channels extending upward and downward into the thrombus body from the
poles. (C and D) Whole mounts (7x) of injured left common carotid arteries and
uninjured right common carotid arteries, as positioned in the animal during surgery.
Hatched lines indicate on injured arteries where representative sections were sampled.
Brace on mutant artery denotes length of opacity correlating to occlusive thrombi in
images. (E) Appearance of neovascular channels (arrows) penetrating the arterial media
in mutant arteries both in areas with occlusive thrombus (upper right) and in areas with
mature neointima (lower left), as compared with near total absence in wild-type arteries
(upper left). Insets (100x) show endothelial cell lining. Positive CD31 stains of cells
occupying these vascular channels (40x and 100x) confirm the presence of immature
endothelial cells and/or circulating endothelial cell precursors (lower right).

49

To determine if Col3a1 haploinsufficiency alters vascular wound healing after
injury by carotid ligation, we ligated left common carotid arteries from 5.5-month old
mice (N = 8 Col3a1+/+, 9 Col3a1+/-) and harvested the arteries at post-operative day 21
(POD21). We serially sectioned the entire length of the vessels from the distal blind
pouch formed by the ligature down to the proximal branchpoint from the ascending
aorta, subjecting every tenth slide to H&E stain to create a series of index slides. Thus, a
representative map was constructed of the complete histological response as it varied
along artery length. Normal wild-type arteries show limited residual fibrinoid thrombus
near to the ligature, medial thickening along the entire length, and a more proximally
located mature neointimal lesion, i.e., distant from the ligature (Figure 2.10A). A
complete depiction of index slides derived from the entire length of a representative
Col3a1+/+artery is contained in Figure 2.11.
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Figure 2.11. Representative map of varying morphology along the length of
injured Col3a1+/+ arteries at 21 days post-injury. Index images photographed from
every tenth slide systematically collected during serial section. Organized here from
right-to-left and top-to-bottom along the distal-to-proximal orientation, picturing the
pole near the ligature at top left and the pole near the branchpoint from the aorta at
bottom right. Whole mounts included for correlation with histology.
In contrast, many Col3a1+/- arterial segments resemble their Col3a1+/+
counterparts in terms of medial thickening and isolated lengths of neointimal scarring,
but we noted a significantly higher number that contain thrombi (Table 2.2, p = .0289).
These segments displayed features of active thrombus organization, including matrixrich luminal contents containing floridly dense myofibroblasts, macrophages (as
determined below), and endothelialized vascular channels penetrating the thrombus
(Figure 2.10B). A complete depiction of index slides derived from the entire length of a
representative Col3a1+/-artery is contained in Figure 2.12, which demonstrates the linear
continuity between areas notable for classic neointimal hyperplasia and those notable for
recanalizing thrombus via axial neovascularization.
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Figure 2.12. Representative map of varying morphology along the length of injured
Col3a1+/- arteries at 21 days post-injury. Index images photographed from every
tenth slide systematically collected during serial section. Organized here from right-toleft and top-to-bottom along the distal-to-proximal orientation, picturing the pole near
the ligature at top left and the pole near the branchpoint from the aorta at bottom right.
Whole mounts included for correlation with histology. Note the continuity between
segments depicting classic neointimal hyperlasia with segments containing resolving
thrombus and recanalization by neovascularization. Arrows indicate medial vascular
channels.
It was also notable that uninjured right common carotid arteries do not differ in
gross histological appearance or size between Col3a1+/- and Col3a1+/+ mice, as apparent
both on whole mount (Figure 2.10C and D) and in cross section (data not shown),
consistent with findings from Liu, et al.15. Thus, differential morphology is locally
limited to areas of arterial injury.
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Persistent neovascularization occupies media of injured Col3a1+/- arteries at 21 days.
In addition to the increased thrombus burden of ligated carotids from Col3a1+/versus wild-type mice, blood-filled vascular channels are present within the medial layer
of mutant arteries (arrows, Figures 2.10B and E and 2.12) and absent in wild-type
carotids (Figures 2.10A and E and 2.11). Immunostaining for immature endothelial cells
using an antibody directed against the CD31 marker not only confirmed endothelial
lining of intrathrombotic vascular channels but also identified CD31-positive cells
within the vascular channels of the media. Often these channels appeared near to CD31positive vaso vasorum in the adventitia or to CD31-positive intrathrombotic clefts in
resolving thrombi, and sometimes they appeared in between both (Figure 2.10E). This
evidence suggesting neovascularization in Col3a1+/- arteries occurred not only in
segments of still-active thrombus resolution but also in remote sections containing
mature neointimal scars (Figure 2.10E), even occurring in Col3a1+/- arteries in which no
residual thrombi were detected at all. Arterial segments containing vascular channels,
although rare within any individual artery, were present at least once in almost all
arteries from Col3a1+/- mice, in comparison to a near complete absence in those from
Col3a1+/+ mice (Table 2.2, p = .0016).
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Table 2.2. Incidence of occlusive thrombi within the lumen and blood-filled
channels within the media of arteries at 7, 14, and 21 days after carotid ligation.
Although N denotes number of mice receiving carotid ligation from wild-type and
mutant groups, respectively, we compared the number of slides positive or negative
for thrombi or blood-filled channels in each of the groups to the expected
hypergeometric distribution for statistical analysis using the Fisher's exact test.
Results showed no difference in incidence of thrombi or channels at POD 7, no
significant difference in incidence of thrombi at POD14 but a very significant
increased incidence of neovessels in mutant arteries, and significantly increased
incidence of thrombi and very significant increased incidence of neovessels in mutant
arteries at POD 21. POD = post-operative day.
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Delayed thrombus resolution and increased incidence of medial neovessels are a late
consequence of carotid ligation.

Figure 2.13. Morphology of thrombus and neovessels in wild-type and mutant
arteries at 7 and 14 days after carotid ligation. Top, At POD 7, wild-type and
mutant arteries harbored minimal fibrin-rich thrombi (pink acellular material) in the
lumina, as depicted in the five most distal arterial segments collected as index slides.
Bottom, In stark contrast, both wild-type and mutant vessels at POD 14 often
contained thrombi floridly dense with myofibroblasts and invaginating clefts that
were lined by endothelial cells. Although arteries from both genotypes contained
medial neovessels (arrows), the overabundance in mutant arteries diverged
significantly by 14 days.
We sought to determine if the increased thrombus burden observed 3 weeks after
carotid ligation in mutant mice resulted from differences in early thrombogenesis. To
address this question, carotid arteries were harvested 7 days (N = 4 Col3a1+/- arteries, 4
Col3a1+/+ arteries) and 14 days (N = 4 Col3a1+/- arteries, 7 Col3a1+/+ arteries) after
ligation for systematic histological analysis performed as described above. At postoperative day 7 (POD7), minimal acellular fibrinoid thrombi, if observed at all, were
located just proximal to the ligature and occupied a relatively low proportion of arterial
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segments (Figures 2.13, 2.14, and 2.15). Between the two genotypes, there were no
differences in the frequency of early thrombogenesis (Table 2.2; p = 1.000).

Figure 2.14. Representative map of varying morphology along the length of
injured Col3a1+/+ arteries at 7 days post-injury. Note the paucity of occlusive
thrombogenesis at the distal pole of the artery. A slight fibrinous layer encircles the
lumen in more proximal segments.

Figure 2.15. Representative map of varying morphology along the length of
injured Col3a1+/- arteries at 7 days post-injury. As in 2.13, note the paucity of
occlusive thrombogenesis at the distal pole of the artery. Also, a similar fibrinous layer
lines the lumen in some more proximal segments.
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In arterial segments from both genotypes in this early phase of vascular wound
healing, we also note blood-filled spaces within the medial layer, although histologic
characteristics suggest a process apart from neoangiogenesis. These spaces lack the
circumscribed appearance of neovessels from Figure 2.10E and instead occupy thin
bands or gaping tracts within the media, often in areas lacking nuclei of resident smooth
muscle cells. We speculate that red blood cells within acellular areas of fibrinoid
necrosis in the wall may have arrived by means less purposeful than neoangiogenesis
and possibly arrived secondary to local weakening of injured arteries during early
hemostasis. In any circumstance, the appearance of blood-filled spaces occurs at similar
frequencies in arteries from both groups (Table 2.2; p = 0.8462).

Figure 2.16. Representative map of varying morphology along the length of
injured Col3a1+/+ arteries at 14 days post-injury. Note hemosiderin-laden
macrophages migrating into the acellular fibrin-rich thrombus at the distal pole,
followed by invaginating clefts. In more proximal segments, fibrinous collar lined by
endothelial cells. Central occlusive thrombi are densely cellular and contain newly
synthesized matrix, showing progressive resolution with decreasing distance from the
more proximal pole.
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To examine the intermediate steps in the progression of thrombus organization
we examined injured left common carotid arteries after 2 weeks (POD14). These
arteries show the greatest morphological variation along the length of organizing
thrombi, with the most advanced stages of resolution and nearly complete recanalization
seen near the proximal pole and primitive fibrin-rich thrombi containing hemosiderinladen macrophages and initial recruitment of fibroblasts at the peripheries in segments
nearest to the ligature at the distal pole (Figures 2.16 and 2.17). The thrombus burden in
both mutant and wild-type arteries increases dramatically between POD7 and POD14,
and the total burden at POD14 was statistically equal in both genotypes (Table 2.2; p =

Figure 2.17. Representative map of varying morphology along the length of
injured Col3a1+-+ arteries at 14 days post-injury. Note macrophages migrating into
the acellular fibrin-rich thrombus at the distal pole and endothelial lining continuous
with fibrinous collar. In more proximal segments, occlusive thrombi are densely cellular
and contain newly synthesized matrix, showing progressive resolution with decreasing
distance from the more proximal pole and even resolving into areas with the appearance
of classic neointimal formation. Abundant neovessels are apparent in segments
surrounding actively resolving thrombi.
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1.000). However, Col3a1+/- contain a very significant higher number of segments
containing medial neovessels, similar to the findings at POD21 (Table 2.2; p = .0065).

Unresolved thrombi in Col3a1+/- arteries at 14 and 21 days post-injury retain higher
burdens of inflammatory macrophages.
The increase in medial neovessels in Col3a1+/- segments at POD14 suggests
increased pro-neoangiogenic signaling in association with a deficiency in new synthesis
of type III collagen in the resolving thrombus. Infiltration of thrombi with inflammatory
cells, including first-wave neutrophils and second-wave macrophages, is normally
necessary for effective wound healing in the skin. This inflammatory phase of wound
healing then initiates the recruitment of fibroblasts and sustains their subsequent
orchestration of the proliferative phase28. Within the parallel scenario of thrombus
resolution, we sought to determine whether any differences between Col3a1+/- and
Col3a1+/+ arteries in the numbers of macrophages residing in the thrombi could possibly
contribute to differential regulation of thrombus resolution.
Arterial segments from POD7, POD14, and POD21 slide sets were
immunoprobed for the mouse macrophage marker, Mac2. Mac2-postive cells were
counted in all sections representing occlusive thrombi, revealing no significant
differences at POD7 (Figure 2.18; N = 8 Col3a1+/+, 7 Col3a1+/- segments; p = .5698) but
an extremely significant higher mean number of macrophages per segment of occlusive
thrombus in Col3a1+/- arteries at POD14 (Figure 2.18; N = 44 Col3a1+/+, 24 Col3a1+/segments; p < .0001).
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By POD21, the number of Col3a1+/+ segments containing occlusive thrombus
decreases dramatically (Table 2.2) with a low number of macrophages identifiable in the
residual thrombi. Macrophages residing in Col3a1+/- segments, on the other hand,
maintain very significant higher numbers on average through POD21 (Figure 2.18; N = 7
Col3a1+/+, 19 Col3a1+/- segments; p = .0036). Notably, many of these segments retain
the high-density, high-activity appearance described at POD14, and some segments even
contain numbers of inflammatory cells in excess of those identified at the earlier
timepoint.

Figure 2.18. Macrophage burden in occlusive thrombi at 7, 14, and 21 days after
carotid ligation. Thrombi were immunoprobed with an antibody directed against the
mouse macrophage marker, Mac2. Counts revealed significantly higher numbers in
mutant arteries at POD14 and POD21 but not in POD7. Note that the mean numbers
increase at POD14 and are maintained at POD21 in mutant thrombi but slightly increase
and peak at POD14 but regress by POD21 in wild-type thrombi.
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Unresolved thrombi in Col3a1+/- arteries at 14 and 21 days post-injury contain higher
numbers of proliferative myofibroblasts.
As thrombus burden increases with time from POD7 to POD14 (Table 2.2),
apparently through the synthesis of new matrix by resident myofibroblasts (Figures 2.16
and 2.17) , we attempted to determine if the proliferative behavior of myofibroblasts
could potentiate thrombus burden and contribute to a scenario akin to unresolved
granulation tissue and fibrocontracture73, perhaps helping explain the persistence of
macrophages and neovessels at POD14 and persistence of thrombus at POD21. Arterial
segments again from POD7, POD14, and POD21 were stained with antibodies directed
against the nuclear phospho-histone H3 (pH3) marker of mitotic cells.
Quantitation of pH3-positve nuclei demonstrate a very significant higher mean
number of mitotic cells per segment of occlusive thrombus in Col3a1+/- arteries at
POD14 (Figure 2.19; N = 42 Col3a1+/+, 24 Col3a1+/- segments; p = .0059) and at
POD21 (N = 6 Col3a1+/+, 22 Col3a1+/- segments; p = .0038) but not as early as POD7
(N = 7 Col3a1+/+, 7 Col3a1+/- segments; p = .5523). Although many segments from
Col3a1+/+ arteries also contain a large number of mitotic cells in areas of fulminant
proliferative phase wound healing at POD14, we observed yet higher numbers of
proliferative myofibroblasts in Col3a1+/- thrombi. Similar to the assessment of
macrophage burden, a dramatic drop occurs in the number of mitotic cells present in the
few residual Col3a1+/+ thrombi at POD21, while the average number of mitotic cells in
Col3a1+/- thrombi continues to increase (Figure 2.19).
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Figure 2.19. Number of proliferative myofibroblasts in occlusive thrombi at 7, 14,
and 21 days after carotid ligation. Thrombi were immunoprobed with an antibody
directed against the proliferative marker, phospho-histone3 (pH3). Counts revealed
significantly higher numbers in mutant arteries at POD14 and POD21 but not in POD7.
Note that the mean numbers progressively increase with time in mutant thrombi but peak
at POD14 and regress by POD21 in wild-type thrombi.

Discussion
Low baseline expression of Col3a1 in uninjured carotid arteries, when compared
to dramatic situational upregulation in response to injury (Figure 2.9B), suggests that
extant type III collagen contributes a relatively minor role in the maintenance of baseline
arterial wall function. Although haploinsufficient mice do express lower message levels
at baseline (Figure 2.9A), this difference is negligible compared to the differences likely
unmasked by injury, as rapid upregulation we have observed in normal injury responses
would quickly outpace maximal expression rates in Col3a1+/- tissues. These
observations predict that differential Col3a1 expression and succeeding production of
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type III collagen exerts its influence more consequentially during active arterial
remodeling than at relative rest in a mature vessel. This would help explain the
discrepancy between the clinical effects of type III collagen deficiency on long-lived
haploinsufficient mice grossly indistinguishable from wild-type littermates in a protected
laboratory environment15 and human patients with mutations variably impinging on type
III collagen secretion invariably suffering complications and premature death9.
Histologic features present in occlusive resolving thrombi from injured mutant
arteries at POD 21 in Figures 2.10 and 2.12, as well as occlusive thrombi in injured
mutant and wild-type arteries at POD13 in Figure 2.13, closely resemble features of
healing granulation tissue75, including dense myofibroblast populations within a newly
synthesized and expanding matrix. This commonality between genotypes, at least at
POD14, suggests a physiologic component to formation and growth of occlusive
thrombus, as very little thrombus was detected proportional to the lengths of arteries at
POD 7 (Figure 2.13, Table 2.2). Pathology arises, however, as wild-type thrombi
regress and disappear by POD21, leaving behind residual neointimal scars, while mutant
thrombi continue to expand. Thus, a critical checkpoint determining the transition
between proliferative granulation tissue formation and contraction and maturation of
scar tissue is not reached on time with insufficient production of type III collagen.
Considering increased burdens of inflammatory cells and climbing levels of proliferation
in resident myofibroblasts, these data offer the first hint that myofibroblast behavior
when lacking the ability to secrete required levels of type III collagen orchestrate
ineffective thrombus resolution that mimics fibroproliferative pathology.
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Notably, thrombus burden is equal between genotypes at POD14, although
significant differences in macrophages within the thrombi and neovessels within the
media already emerge. This would specifically implicate the content of the matrix as the
driving force behind the retention of macrophages and pro-angiogenic signaling that
these cells would promote, resulting here in the localization of cells positive for the
CD31 marker of endothelial precursor cells within the medial channels82,83. Whether the
matrix produced by Col3a1 mutant cells actively attracts and retains more macrophages
from hypoxia and/or local factors secreted into the matrix or whether the properties of
the matrix itself speeds or retards cell migration is yet unknown, although expression of
the stromal cell-derived factor-1 (SDF-1) chemokine by perivascular myofibroblasts in
proximity to active angiogenesis has been shown to be critical for the recruitment of
bone marrow-derived circulating cells and the success of VEGF-programmed
neoangiogenesis in adult tissues83.
The linear continuity observed here between polar hotbeds of thrombus
recanalization with segments containing neointimal lesions supports the concept that
mature concentric neointimal scars originate from the successful confluence of such
recanalizing channels (Figure 2.12 and 2.17). The orientation of neointimal lesions at
the inferior, proximal pole of the resolving thrombus suggests that it represents the most
mature phase of vascular wound healing, akin to an organized collagenous scar in healed
skin. Perhaps with the normal resolution of thrombi by the timepoints at which
investigators have examined neointimal lesions, this relationship has been largely
ignored. In the original description of carotid ligation in mice, investigators purposely
disposed of arterial segments through to contain residual thrombus before investigating
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remote neointimal lesions50. Studies of thrombus organization (what few exist) discuss
myofibroblasts and endothelial-lined recanalization, while studies of neointimal
formation discuss smooth muscle cells alone, with the perception that neointimal
hyperplasia is a phenomenon composed primarily of proliferation of local smooth
muscle cells and reflected entirely in morphometric measurements of neointimal
thickening84. Unfortunately, the distinction between myofibroblast and smooth muscle
cells is subtle, with both cell types expressing smooth muscle-specific α-actin.
Nonetheless, the data presented here where thrombus resolution is delayed is important
for providing a novel paradigm from which to view and investigate neointimal
formation: as a product of specialized cells behaving as hybrids of fibroblasts and
smooth muscle cells, rather than one or the other, to enact thrombus resolution.
This study is not the first to describe thrombus resolution as a process embodying
wound healing in the vasculature and a precursor process to neointimal formation.
Investigators directly injuring arteries in pigs to induce stenotic neointimal formation
identified an early thrombotic phase involving fibrin and platelets, an inflammatory and
endothelial cell recruitment phase, and a proliferative phase in which "smooth muscle
cells" migrate into and proliferate within fibrin-rich thrombi65. Authors take care to note
that popular conceptions of neointimal proliferation and therapeutic strategies to inhibit
the process fail to consider these upstream "humoral" and "cellular" events, specifically
identifying the cellular production of extracellular matrix as a suitable target for
modifying neointimal thickening65.
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Chapter 3: Dysfunctional Matrix Remodeling by Myofibroblasts from vEDS
Patients and Type III Collagen-Deficient Mice
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Introduction
Myofibroblasts: Regulators of Wound Healing
The myofibroblast is a cell type first isolated from granulation tissue, noted to
possess composite synthetic properties of fibroblasts and contractile properties of
SMCs85. The ability of fully differentiated myofibroblasts to contract results from the
expression of ACTA2, which encodes the smooth muscle-specific isoform of α-actin (αSMA) monomers that form contractile filaments similar to those observed in SMCs86.
Quiescent fibroblasts require stimulation with transforming TGF-β1 to differentiate into
myofibroblasts, and myofibroblast contraction initiates a positive feedback loop by
stretch-based release of further active TGF-β1 from its latent form bound to the
extracellular matrix87-89.
However, TGF-β1 alone is not sufficient, as cellular expression of contractile αSMA in response to TGF-β1 also requires sustained tensile resistance from the
substratum the cell is attempting to contract, implicating α-SMA as a mechanosensitive
protein90,91. In fact, bipolar cells and actin filaments align in planes parallel to a wound
surface along the vector of greatest strain, i.e., along the long axis of a wound, rather
than extending perpendicularly across its gaping width92. Cells replicate this alignment
when cultured within a strained three-dimensional in vitro matrix lattice93.
Myofibroblasts are the major actors in wound healing, essentially dictating the
tipping point where the proliferative and tissue forming phase matures into the tissue
remodeling and contraction phase. Almost all mature connective tissues exist under a
native mechanical tension, even at rest, as demonstrated by the shrinking length or width
of vessels, nerves, or punch biopsies of the skin upon dissection away from the body.
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Thus, the volume of new and immature granulation tissue requires compaction to
reestablish a "tension homeostasis," and this occurs as a function of both contractile
force generated by the resident cells and the stiffness of the matrix they must contract.
Myofibroblasts, which are both synthetic and contractile, modulate both parameters in
turn94.
Expression levels of α-SMA directly correlate with contractile force generated by
myofibroblasts95, and release of compacted matrix gels from the dishes and wells to
which they have been originally tethered, thus neutralizing stress opposing cellular
contraction within the tissue, allows measurement of the immediate shortening of the gel
to reflect the relative contribution of active, energy-dependent contraction96. However,
myofibroblasts do not contract indefinitely in granulation tissue to maintain tension (a
process that would require untenable energy input). Instead, they introduce tension by
semi-permanently remodeling the arrangement of newly synthesized matrix. After
contractile forces incrementally compact local fibers, cells structurally "lock" those
fibers in place by yet unknown mechanisms to form a denser, stiffer material. This
defines the distinction between contraction and contracture97-99 (Figure 3.1). Not only
deposition but, critically, the succeeding rearrangement of matrix re-establishes native
stress shielding of cells residing in connective tissue. This term describes how the
design properties of the arranged matrix allow it to bear tensile load preferentially over
the myofibroblasts93, after which cellular contraction is no longer necessary and α-SMA
expression decays97,100.
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Figure 3.1. Model of extracellular matrixremodeling phase of matrix contracture. Matrix
contracture is mediated by myofibroblasts. How is the
contractio of myofibroblasts translated into functional
collagen-network shortening? The following working
hypothesis serves to define some basic mechanisms.
(a) Myofibroblasts are embedded in a collagen
network. These cells bind to collagen fibrils through
fibronexus adhesion complexes that are linked to
intracellular stress fibers. (b) Cytoskeletal or signaling
events in one of these myofibroblasts leads to stressfiber contraction, which results in local matrix
contraction, shortening, and bundling of the
surrounding pericellular collagen network. As this is a
local effect, its consequences are incremental, and
affect at most a few surrounding cells and matrix. (c)
New matrix components are added to stabilize the new
collagen organization, relative to its neighbors. The
addition of collagen would potentially increase
collagen density and orientation. (d) The
myofibroblast that contracted originally, as well as
other surrounding myofibroblasts, can repeat the
process so that this small incremental collagen-matrix
remodeling can result in tissue contracture. Reprinted
with permission from Nature Publishing Group
[Myofibroblasts and mechano-regulation of connective
tissue remodeling. Tomasek JJ, Gabbiani G, Hinz B, et
al. Nature Reviews Molecular Cellular Biology.
2002].
Timing is everything, as the rate of effective remodeling not only determines the
length of the window during which the strength of tissue is compromised but also the
cumulative amount of energy input necessary to re-establish homeostasis. Thus, delayed
rates of new type III collagen production likely alter the course of this process, as
suggested by experiments explanting fetal skin fibroblasts from Col3a1+/+, Col3a1+/-,
and Col3a1-/- littermates. Cells were seeded into type I collagen gels and allowed to
contract and remodel the experimental matrix for 5 days. Disrupting the adhesion of the
gels from the culture dishes to which they were tethered reveals a more effective
shortening of the tissue by mutant fibroblasts. This active, cell-mediated contractile
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response to release of tension implicates a higher dependence on cellular contraction for
tissue compaction prior to release, and here the increasing dependence on contraction
emerges as a function of the increasing genetic impediment to synthesizing new type III
collagen (Figure 3.2).

Figure 3.2. Collagen gel contraction by wild-type and type III collagen-deficient fetal
(~E18.5) dermal fibroblasts. Wild-type and type III collagen-deficient fibroblasts were
grown in attached collagen gels for 5 days. Stressed lattices were then released and the
percentage of contraction calculated at 30, 60, 120, and 240 minutes post-release. Values
represent means ± SEM. Col3a1+/- and Col3a1-/- values were found to be significantly
different from Col3a1+/+ values at all timepoints. Reprinted with permission from
Karger Publishers [Diminished type III collagen promotes myofibroblast differentiation
and increases scar deposition in cutaneous wound healing. Volk SW, Wang Y, Mauldin
EA, et al. Cells Tissues Organs. 2010].
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Figure 3.3. Increased α-SMA expression by type III collagen-deficient (Col3a1+/- and
Col3a1-/-) cells compared to wild-type (Col3a1+/+) cells. Cells from all 3 genotypes,
utilized in an attached fibroblast-populated collagen gell assay, were immunostained for
α-SMA (green) and counterstained with DAPI (blue). (a) Myofibroblasts within
collagen lattices were identifiied by α-SMA expression. α-SMA incorporation into
stress fibers (arrows) could be visualized in cells from all 3 genotypes. (b-d)
Representative images showing the percentage of myofibroblasts in cultures of
Col3a1+/+ (b), Col3a1+/- (c), and Col3a1-/- (d) cells are presented. Reprinted with
permission from Karger Publishers [Diminished type III collagen promotes
myofibroblast differentiation and increases scar deposition in cutaneous wound healing.
Volk SW, Wang Y, Mauldin EA, et al. Cells Tissues Organs. 2010].
Staining tethered gels with fluorescent anti-α-SMA antibodies elucidates higher
burdens of persistently α-SMA-expressing myofibroblasts in type III collagen-deficient
cultures, in comparison with wild-type cultures (Figure 3.3), where α-SMA expression
has possibly already peaked and receded secondary to stress-shielding via more effective
remodeling of the matrix. Following full-thickness excisional punch biopsies in the skin
of aged adult Col3a1+/+ and Col3a1+/- mice (>1 year), type III collagen-deficient animals
also demonstrate accelerated wound closure and significantly less wound area by 7 days,
even for wounds created on the dorsal skull that were effectively splinted open by the
tension of skin over bone. Immunohistochemical staining of wound cross-sections
confirmed dramatically robust α-SMA expression in the granulation tissue of Col3a1+/mice compared to wild-type mice101 (Figure 3.4).
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Figure 3.4. Wounds in aged type III collagen-deficient mice show increased wound
contraction and granulation tissue α-SMA expression. Immunohistochemcial staining
for α-SMA (brown) in representative wounds from Col3a1+/+ (a) and Col3a1+/- (b) mice
7 days after wounding by excisional punch biopsy. Detailed views of the granulation
tissue and overlying neoepithelium in wounds from Col3a1+/+ (c) and Col3a1+/- (d)
mice reveal increased α-SMA immunoreactivity in wounds from type III collagendeficient mice (Col3a1+/-) compared to wild-type mice. Reprinted with permission
from Karger Publishers [Diminished type III collagen promotes myofibroblast
differentiation and increases scar deposition in cutaneous wound healing. Volk SW,
Wang Y, Mauldin EA, et al. Cells Tissues Organs. 2010].

The Role of Type III Collagen in Matrix Remodeling
Some speculate that matrix remodeling to restore tension homeostasis and stress
shielding of cells may depend on the de novo production of type III collagen, which has
been proposed to serve as a provisional matrix special to granulation tissue.
Specifically, the temporary presence of type III collagen has been suggested to reduce
the vulnerability theoretically arising from a situational breakdown of type I collagen
cross-links to allow slipping of fibrils for compaction98. Soon after the original isolation
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of the myofibroblast from granulation tissue, researchers investigating its synthetic
products in vivo discovered a distinctly high proportion of type III (30-35%) within total
collagen digested from granulation tissue, more resembling embryonic skin in relative
collagen content than adult dermis. However, with the resorption of granulation tissue
and the resolution of wound healing, this high proportion of type III collagen disappears
simultaneously with the disappearance of α-SMA expression, and the vast majority of
dermis collagen again consists of type I collagen76. In this way, the content of the
matrix synthesized, namely the accumulating content of type III collagen, during the
tissue formation phase may determine the ability of granulation tissue to progress to the
final contraction and resolution phase of wound healing.
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Figure 3.5. Gene expression of collagen type III α-chain (A and D) and collagen type
I α-chain (B and E) over 7 days in culture. Results are normalized relative to 3D
collagen on day 1. Two matrix geometries were used: two-dimensional monolayer
culture (2D) and three-dimensional matrices (3D). The matrix materials used were
tissue culture plastic (TCP), collagen (C), collagen-fibrin (CF), and fibrin (F). Panels
A and B depict the effects of matrix geometry on matrix gene expression at day 3,
which is representative of the temporal data. Panels D and E show the effects of
matrix composition in 3D systems over time in culture. RT-PCR results were
normalized to GAPDH expression at each timepoint and for each matrix condition.
Results are expressed as the mean ± SEM. Reprinted with permission from Taylor &
Francis [2D and 3D collagen and fibrin biopolymers promote specific ECM and
integrin gene expression by vascular smooth muscle cells. Hong H, Stegemann JP.
Journal of Biomaterials Science, Polymer Edition. 2008].

Indeed, seeding fibroblasts and SMCs into different three-dimensional matrix
polymers, which are compacted from hydrated hemispheres into flattened disks within
24 hours, elicits differential production of new matrix. Seeding cells into a fibrin lattice
resembling a fresh thrombus induces robust early expression of Col3a1 that attenuates
over 7 days102. Seeding cells into a lattice with a 1:1 ratio of fibrin and collagen to
model a partially remodeled thrombus elicits weak expression of Col3a1 but more robust
and increasing expression of Col1a1 over 7 days, suggesting a positive feedback for type
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I collagen production as type I collagen begins to accumulate102 (Figure 3.5D and E).
Scanning electron microscopy images acquired 4 weeks after seeding fibroblasts in
fibrin matrices visualize this initial ramping of local fibrillar collagen production103

Figure 3.6. Representative scanning electron microscopy images of fibroblast-remodeled
fibrin construct after 4 weeks. Depicted in the bottom left image is a cell embedded in the
fibrin matrix. By week 4, the emergence of collagen fibril bundles embedded in the fibrin
matrix becomes more apparent. In the top image, collagen parallel fibril bundles can be
identified from the surrounding fibrin by the parallel bundling. The asterisk shows the
location of the magnified region on the bottom right. Collagen fibrils in the interior were
always identified near cellular material. Reprinted with permission from Springer [Initial
fiber alignment pattern alters extracellular matrix synthesis in fibroblast-populated fibrin
gel cruciforms and correlates with predicted tension. Sander EA, Barocas VH, Tranquillo
RT. Annals of Biomedical Engineering. 2011].
(Figure 3.6). Nonetheless, Col1a1 expression by cells within pure type I collagen
lattices only modestly increases over 7 days, implicating a negative feedback dampening
of synthesis by collagen accumulation that has reached a certain threshold102 (Figure
3.5E). It is striking that none of this dynamic expression is observed in cells grown in
monolayers on two-dimensional matrix substrates, suggesting not only that threedimensional interaction with matrix ligands induces distinct signaling through cell-

75

surface receptors but also that tensional forces developing in tethered and compacted
matrices provide additional, critically amplified stimuli (Figure 5.5A and B).
Deranged collagen fibrils in vEDS patients and Col3a1-/- mice have already
demonstrated the necessity of type III collagen for normal, uniformly organized type I
collagen fibrillogenesis. Both in vitro and in vivo basic studies of the actual formation of
fibrils illustrate a more specific mechanism. In the developing metatarsal tendons of
chick embryos, immature tendons show even distribution of type I and type III collagen
and uniformly small fibrils. During a period of rapid development of fibrils, however,
the two types of collagens segregate between the fascicle (high type I collagen) and
investing connective tissue compartments (high type III collagen), where fascicular
fibrils are larger and the fibrils in sheaths remain small until type III collagen levels
eventually disappear, such that levels of type III collagen negatively correlate with
developing fibril diameter104.
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Figure 3.7. Morphometric analysis of collagen I fibrils and copolymer fibrils of
pNcollagen III and collagen I by dark field and electron microscopy. Control
collagen I fibrils were generated by cleaving pCcollagen I with C-proteinase, and
copolymers were generated by cleaving procollagen III and pCcollagen I with Cproteinase. Upper left, Dark-field light microscopy of control collagen I fibers.
Lower left, Dark-field microscopy of copolymer fibrils. The heterogeneous
copolymer fibrils were longer and thinner and appeared more flexible than the control
fibers of collagen I. Upper right, Control collagen I fibril (A), copolymer generated
from an initial molar ratio of 0.5:1 (B), 1:1 (C), and 2:1 (D) of III: I. Reprinted with
permission from The American Society for Biochemistry and Molecular Biology
[Copolymerization of pNcollagen III and collagen I. Romanic AM, Adachi E, Kadler
KE, et al. Journal of Biological Chemistry. 1991].
In vitro cell-free systems demonstrate that partially-cleaved type III procollagen
(type III pNcollagen) copolymerizes with type I collagen when they are both newly and
simultaneously cleaved from type III procollagen and type I pCcollagen, respectively.
The presence of type III pNcollagen increases lag for incorporation of type I collagen
into fibrils, lowering the maximum rate and decreasing the steady-state concentration of
type I collagen incorporated. Again, relative proportions of type III pN collagen
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negatively correlated with fibril diameter, with the resulting copolymer fibrils
demonstrating greater flexibility (Figure 3.6). The kinetics of assembly best fit a model
in which type III pNcollagen coats the circumference of developing fibers except at the
growing tips105.

Stress Shielding, Apoptosis, and Fibrocontractive Disease
Resolution of granulation tissue following tissue compaction involves a drop in
cellularity and vascularity of the scar through incremental apoptosis of myofibroblasts
and neovessels. The same is true for the cellularity of neointimal lesions with maturity
over time106. When apoptosis fails to occur following wound healing, hypertrophic
scars, keloids, or disfiguring contractures can develop as α-SMA-expressing cells
continue to proliferate and generate granulation tissue even after wound closure. Indeed,
fibrocontractive diseases of many organs involve the inappropriate and prolonged
activity of dysregulated myofibroblasts98,79.
The co-occurrence of stress shielding, loss of α-SMA expression, and apoptosis
in maturing granulation tissue, as well as efforts to experimentally release splinted
wound tension and resulting observations of acutely marked apoptosis in the newly
unstressed granulation tissue107, has led to the notion that loss of mechanical tension may
provide the signal to initiate programmed cell death108-110. This notion is consistent with
the long clinical experience of surgeons, who note that wounds bearing tension develop
hypertrophic scars. In fact, externally applied mechanical loads to wounds (splints)
during the early proliferative phase of healing inhibit apoptosis for several weeks
afterward and were sufficient to induce hypertrophic scars in experimental animals. The
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increased volume of granulation tissue corresponded to increased cellularity and not to
increased production of collagen per individual cell, which statistically equaled that in
unloaded tissue111.
As the regulation of myofibroblast behavior appears exquisitely sensitive to
mechanical interactions with their surrounding matrix, and as diminutive levels of type
III collagen may possibly promote more rigid and less flexible matrix, for the second
aim of this project, we seek to confirm dysregulation of myofibroblast activity in type III
collagen-deficient tissues. In injured Col3a1+/- mouse arteries, we confirm impaired
synthesis of type III collagen by α-SMA-positive myofibroblasts in resolving thrombi at
POD14, compared to wild-type levels, alongside evidence of increased type I collagen
deposition in mutant tissues, which progresses by POD21 to deranged remodeling of
wider collagen fibers on average within neointimal lesions from mutant arteries. By
seeding human dermal fibroblasts from vEDS patients with missense mutations of
various inefficiency at secreting type III collagen into thrombus-mimicking fibrin gel
constructs, we unmask abnormally high transcription of ACTA2, the gene encoding αSMA, and abnormally delayed transcription of both COL3A1 and COL1A2, one of the
genes encoding type I collagen. We also visualize the deposition and rearrangement of
collagen by these cells over time, discovering that type III collagen-deficient cultures are
dramatically impaired in their ability to remodel collagen networks within stressed
lattices.

Methods
Nonlinear Optical Microscopy of Collagen in Post-Injury Tissues
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From our cohort of POD14 index slides as described in Chapter 2, we identified
arterial segments with morphology consistent with the proliferative phase of vascular
wound healing, including dense myofibroblast cellularity, expanding matrix production,
and relatively high macrophage burdens. From our cohort of POD21 index slides, we
identified arterial segments containing the apical neointimal lesion within an individual
artery, i.e., the lesion representing the highest proportional occlusion of the artery lumen.
Here we emphasize that extent of occlusion in the apex does not hold particular
biological relevance to our investigation of remodeling in granulation tissue except to
provide the greatest allowable area for image sampling within an individual segment.
Apices were often situated near the center of axially oriented lesions, providing a
reliable criterion by which to choose slides comparable across individual arteries.
We selected unstained slides that correspond to neighboring index slides
containing suitable morphology (N = 5 Col3a1+/+ slides from 1 artery, 5 Col3a1+/- slides
from 1 artery at POD14; and 5 Col3a1+/+ slides from 5 arteries, 7 Col3a1+/- slides from 7
arteries at POD21). Slides and tissues were deparaffinized and rehydrated by
immersion in xylenes followed by immersion in a graded alcohol series. Tissue sections
were then submerged in PBS until ready for imaging by nonlinear optical microscopy, or
NLOM.
NLOM is an imaging technique designed for the specific visualization of
collagen fibers within a wet, biologically intact tissue. The optical engineering of the
custom-built, laser-based system has been described previously112. Relevant to data
acquisition for the current experiments, NLOM captures two spectrally distinct signals,
two-photon excited fluorescence (TPF) produced by resident cell cytoplasm and second-

80

harmonic generation (SHG) produced by the highly-ordered and birefringent molecular
structure of fibrillar collagen113,114. Overlay of the two signals acquired from one tissue
through a 40x objective (via customized software openly available, see
http://biomed.tamu.edu/tml) spatially relates tissues or cell bodies and processes with
their extracellular matrix.
At the time of imaging, tissues remained submerged under PBS on the slide
through the use of hydrophobic ink to encircle the sections. The 40x aqueous objective
was centered over the neointimal lesions and the images scanned by the laser in one
plane to generate both TPF and SHG signal images. At high power, it quickly became
obvious that SHG signal from abundant adventitial collagen saturated the sensitivity of
the imaging software to neointimal fibers. We carefully situated tissues so that a
standardized field of view captured by the software only contained neointimal or medial
signals. The field of view (FOV) is defined by the software in computational units of 1
to 2.5, increasing in value with increase in power, and here we mostly utilize FOV 2.0 to
image entire sections and FOV 1.5 to limit field to neointima. FOV is correlated with
actual distance through the electronic regulation of movements of the microscope stage
on the order of microns, with scale bars obtained through comparison of repeated images
obtained after moving the stage a precise distance.
It also became obvious that the diameter and density of collagen fibers, much
like cell density visible on H&E, varies locally within an individual artery segment. In
order to reflect local diversity in the quantification of SHG, we captured images by semirandomly centering the field of view over segments of the neointima in each slide,
producing between 4 and 8 images per slide depending on the available neointimal area.
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For each image, NLOM quantified a mean SHG signal intensity in arbitrary units within
a region-of-interest (ROI) drawn to solely encompass neointima. Mean signal intensity
arises as a function of not only the presence of collagen fibers within the ROI but also of
the diameter of those individual fibers. Because the signal intensity measurement
reflects autoregulation by the software to maximize imaging sensitivity, we took
painstaking care to optimize focus of the objective onto the plane of the tissue to achieve
maximum signal. We then normalized each mean neointimal intensity value to the mean
intensity of an ROI drawn around the SHG signal generated by the internal elastic
lamina, which we assume to be relatively constant and unaffected by genotype.
Similar to index slides sampled along the length of harvested arteries, each image
represented highly localized phenomena, rather than phenomena uniformly distributed
across the neointima, and presented information that was more unique than similar, even
among images taken from the same arterial section. Thus, images were not treated as
"technical" replicates, as they did not cluster in regard to an individual slide. To avoid
under-representing the variance in the dataset by calculating a mean neointimal/elastin
intensity ratio per slide and subsequently calculating a mean of mean intensity ratios per
genotype, we calculated mean intensity ratios ± standard deviation based on the total
number of images per genotype at POD21 (N = 57 Col3a1+/+ images, 31 Col3a1+/images). The complete set of intensity ratios were graphed as individual data points to
reflect their near normal distributions. To determine statistically significant differences
between the means, we performed an unpaired Student's t test. As POD14 tissues were
more dynamic along the length of arteries and between arteries, it was not possible to
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choose comparable morphologies from every mouse artery, and so statistical hypothesis
testing was underpowered.

Histochemical and Immunohistochemical Evaluation of Matrix
As SHG reflects signal from all fibrillar collagen, including both type I and type
III, we aimed to tease apart tissue expression of type I and type III collagen more
specifically with immunohistochemical analysis. This more blunt technique only
identifies the presence of absence of matrix antigen within a field and offers poor
estimation of relative content between the two genotypes, although correlation between
expression and morphology provides information about the biological circumstances of
expression.
Tissues were prepared prior to incubation with antibody as described in Chapter
2 with routine HIER. Slides were incubated with mouse antibodies directed against
mouse type I collagen (Abcam, Cambridge, MA) and mouse type III collagen
(Biogenex, Fremont, CA) for 1 hour at room temperature. The specificity of structures
stained with anti-collagen I antibody correlated to images obtained with NLOM, and the
specificity of anti-collagen III antibody was confirmed through Col3a1+/- artery
sections serving as negative controls. Slides were photographed and presented at 40x
magnification, unless otherwise specified.
Broader histochemical assay of insoluble matrix, celullar, and mucinous
components within sections was obtained through Movat pentachrome stain, by routine
techniques. Pentachrome stains muscular material red, fibrinous material and blood
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bright red, nuclei and elastin black, proteoglycans and ground substance blue, and
collagen yellow.

Explant of Dermal Fibroblasts from Human vEDS Patients and Col3a1 Mutant Fetal
Mice
Aliquots of dermal fibroblasts from human patients with vEDS and documented
COL3A1 missense mutations of relatively high severity (G769R, G832R, and G1021R)
were a gift of Dr. Peter H. Byers of the Collagen Diagnostic Laboratory and Department
of Pathology at the University of Washington. Dermal fibroblasts from healthy human
control subjects (sex-matched and age-matched to within 10 years of age of patients at
time of harvest) were obtained by our laboratory following informed consent in
accordance with IRB approval of recruitment protocols. Fibroblasts were originally
explanted from the dermis of punch biopsies obtained from the skin of the medial upper
arm and cultured to form expansible cell lines. Briefly, explant involved dipping tissue
into ethanol, PBS, and complete DMEM before scraping away epidermis and
subcutaneous fat, transferring remaining dermis into new tissue culture dishes, and
mincing in fresh DMEM. Sterile glass coverslips are placed to anchor minced tissue
pieces and promote the adhesion and outgrowth of dermal fibroblasts, which are
subsequently trypsinized and expanded within culture flasks by routine cell culture
techniques. Cells are maintained with complete DMEM supplemented with 10% fetal
bovine serum (Atlanta Biologicals) and 100U/ml penicillin, 100µg/ml streptomycin, and
250ng/ml amphotericin B (Gibco).
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Since neonatal Col3a1-/- mouse pups survive until birth but rarely survive to
weaning, much less into adulthood15, we opted to generate Col3a1+/+, Col3a1+/-, and
Col3a1-/- dermal fibroblast lines from fetal mouse tissues. We chose fetal tissues rather
than embryonic fibroblasts, as fetuses have reached the age past which scarless wound
healing (e.g., at E15) transitions to adult-type repair with scarring (at E18)115. We mated
a pair of Col3a1+/- adult mice to generate offspring representing all possible genotypes.
Following observation of a vaginal plug to suggest fertilization at E0.5, we anesthetized
the pregnant female and sacrificed via thoracotomy on E18.5. We dissected out the
uterus under sterile conditions and submerged in sterile PBS. In a dish, we dissected
away the uterine wall to reveal four fetuses ~22mm in axial length, confirming age at
E18. Fetuses were separated into individual dishes and skin harvested, minced, and
anchored by sterile coverslips for establishment of cell lines and maintained using the
same media as described above. Residual tissues were collected for genotyping to probe
for both Col3a1 and Neo alleles80, and results demonstrated a litter yielding 1 Col3a1+/+
cell line, 1 Col3a1+/- cell line, and 2 Col3a1-/- cell lines.

Fibroblast Culture in Three-Dimensional Fibrin Gels
We chose to seed fibroblasts within attached fibrin gel hemispheres, so that TGFβ1- stimulated contraction would decrease thickness but not shorten diameter of the in
vitro tissue, thereby increasing tension. Furthermore, culture within a fibrin matrix
allows for the unambiguous observation of de novo collagen synthesis98,103,116,117. We
scored circles on the plastic surfaces of 35-mm wells in tissue culture plates and 35-mm
dishes by tracing 22-mm diameter glass coverslips with a diamond-tipped pencil before
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sterilizing under UV irradiation for 20 minutes. We reconstituted bovine plasma type IV
fibrinogen (Sigma) in sterile phosphate-buffered saline at 2.5mg/ml and supplemented
with 4mg/ml 6-aminocaproic acid (ACA, Acros Organics) to inhibit degradation of
polymerized fibrin matrices by residual plasmin activity, and we sterilized the solution
by 0.22µm vacuum filtration (Millipore). We also reconstituted 1000U bovine plasma
thrombin (Sigma) in solutions of 0.1% bovine serum albumin (Sigma) for mixture with
fibrinogen solution just prior to plating to give final concentrations of 0.1U thrombin/mg
fibrinogen.
After trypsinizing fibroblasts from hyperconfluent culture in 75cm2 flasks, we
suspended pellets of 5 x 105 human fibroblasts or 2 x 105 fetal mouse fibroblasts in 1ml
fibrinogen solution and mixed with 50µl thrombin solution before plating 1ml
hemispheres of clotting fibrin within scored tissue culture wells and dishes.
Hemispheres were then carefully incubated at 37̊C for 30 minutes in a humidified
incubator to allow complete polymerization of the fibrin lattice. Immediately afterward,
the gels were fed with DMEM freshly supplemented with 10% fetal bovine serum
(Atlanta Biologicals), 100U/ml penicillin, 100µg/ml streptomycin, and 250ng/ml
amphotericin B (Gibco), 50µg/ml ascorbic acid (Sigma), and 4mg/ml ACA (Acros
Organics) and impregnated with 10ng/ml recombinant human TGF-β1 immediately
before use (R&D Systems) to stimulate the resident cells with a pulse of TGF-β1 and
establish the day 0 timepoint.
Plate wells and dishes were subsequently (1) fixed with 4% paraformaldehyde or
10% buffered formalin for 10 minutes and stored wet in PBS and protected from light at
4˚C or (2) aspirated of media, washed with 2ml PBS, and dry frozen at -80˚C after
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precisely 1 day, 3 days, 7 days, or 14 days for (1) imaging of cellular morphology and
organization of collagen and (2) homogenization in TRI reagent and RNA extraction,
respectively. In the meantime, media was replaced on Mondays, Wednesdays, and
Fridays with complete DMEM freshly prepared as above, excepting the addition of
TGF-β1. For control samples to establish baseline RNA levels, pellets simultaneously
formed from identical numbers of fibroblasts were washed in 2ml PBS and immediately
lysed in 1ml TRI reagent and frozen at -80˚C on day 0 without ever being exposed to
three-dimensional fibrin or to TGF-β1 stimulation.

Nonlinear Optical Microscopy of Collagen in Three-Dimensional Gel Cultures
After fixation of gels containing either human dermal myofibroblasts or mouse
fetal dermal myofibroblasts at days 1, 3, 7, and 14, slides and gels were subjected to
NLOM. Fixed discoid gels of 22mm diameter and submerged in PBS were situated
under the aqueous objective so that the laser penetrated the central axis where the gel
was thickest. Images were acquired at FOV 1.0 in planes first intersecting the apical
surface and then incrementally penetrating at 10µm-stepwise depths until reaching the
floor of the dish. Cells extending above and below the plane of the image were captured
by multiple images. In general, cells were clearest and most numerous in the plane
equidistant between the apex and the floor, and images most demonstrative of cell
behavior and matrix interaction are presented here.
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RNA Extraction from Three-Dimensional Gel Cultures and Quantitative PCR

Table 3.1. Forward and reverse primer sequences utilized for quantitative PCR assay.
Detection of SYBR green fluorescence was used to derive relative transcript levels of the
genes listed. Sequences presented in 5' to 3' orientation.
Plates containing three-dimensional gel cultures were dry frozen at -80˚C at the
appropriate timepoint as above, and once all day 1, day3, and day 7 plates had been
collected, gels were thawed on ice and thoroughly scraped from plates using plastic cell
lifters and 0.5ml TRI reagent. Reagent and solid tissues were then each transferred into
individual round-bottom tubes already containing 0.5ml TRI reagent for a combined
volume of ~1ml TRI reagent per gel. For the remainder of RNA extraction, gels were
effectively treated as tissues homogenized with a protocol identical to that described for
harvested arteries in Chapter 2, except that gels each yielded sufficient RNA to be
homogenized separately as individual biological replicates rather than pooled. Samples
homogenized in TRI reagent were then grouped alongside thawed day 0 samples of cell
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pellets lysed in 1ml TRI reagent for further RNA extraction following manufacturer's
instructions (Sigma).
Reverse transcription of cDNA samples was performed using identical methods
to those described in Chapter 2, although one cDNA sample was generated per
biological replicate rather than pooled. Quantitative PCR was performed on a Roche
LightCycler 480 instrument using primers designed in-house for mouse and human
GAPDH, COL3A1, COL1A1, COL1A2, ACTA2, TGFB1, MMP1, MMP2, MMP9,
ITGA1, ITGA2, and ITGB1 (Table 3.1) and reagents available in the LightCycler 480
SYBR Green I Master kit (Roche) according to manufacturer's instructions. Again,
quantification of target gene expression normalized to internal control gene expression
(GAPDH) related message levels from day 1, day 3, and day 7 gels to baseline levels in
an equivalent mass of RNA derived from day 0 cell pellets according to the Comparative
CT method81.
Gel experiments were repeated three separate times for both three mouse and
three human cell lines that differentially secrete type III collagen based on genotype, and
samples from gels plated at the same time for the same experiment were analyzed
relative to each other. We calculated mean fold-changes in gene expression ± standard
deviations from the three biological replicates for each of the cell lines at each of the
timepoints relative to baseline message levels in the type III collagen-sufficient cell lines
at day 0. As we were interested in the differential expression of target genes over time
as a function of COL3A1 genotype, we performed a two-way analysis of variance for
mean fold-changes between samples and post-test analyses between pairs of cell lines
harvested at the same timepoint. Statistical calculations were carried out on GraphPad
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software, and error bars represent standard error of the mean between measurements
derived from technical and biological replicates. We concluded statistically significant
differences in expression when p < .05.

Results
Thrombi remodeled by actin-positive myofibroblasts, resulting in differential collagen
production durring active resolution and formation of mature neointimal lesions.
We attempted to determine whether differential burdens of thrombi or neovessels
at POD21, when contrasts were most pronounced, could be correlated with any
molecular differences in the extracellular matrix of the neointima between Col3a1+/+ or
Col3a1+/- arteries. We restricted our investigation to matrix deep to the internal elastic
lamina, including matrix within residual occlusive thrombi and within more mature
neointimal lesions, since any tissue present must have arisen in response to carotid
ligation and involved de novo synthesis of type III collagen.
Thus, we chose arterial segments both from areas near the center of unresolved
thrombi and from the apex of neointimal lesions for initial histochemical analysis by
Movat pentachrome stain. Most relevant to the matrix content is the distinction between
"muscular" cell bodies in red, collagenous matrix in yellow, and mucinous ground
substance in blue. Despite similar appearance by hematoxylin and eosin stain, Movat
stain reveals a subtle pattern of patches of collagen accumulation around the outermost
edges of Col3a1+/+ thrombus, relative to the more mucinous matrix in the interior.
Matrix is less differentiated In Col3a1+/- thrombus and more categorically yellow
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(Figure 3.8). Cell density in Col3a1+/- thrombus is striking, consistent with significantly
higher numbers of proliferative pH3-positive cells identified in Chapter 2.
As histochemical stains provide relatively nonspecific information, we sought to
hone our analysis of collagen content by imaging slides with nonlinear optical
miscroscopy (NLOM) of second harmonic generation (SHG), which derives images of
intact fibrillar collagen microstructure in situ and corresponds mean signal intensity
within a region of interest to the number and diameter of fibers present112,118. Images
confirmed the relatively increased accumulation of collagen in outer patches of
undulating collagen fibers in the Col3a1+/+ thrombus. The Col3a1+/- thrombus similarly
contains undulating fibers but in a more uniform distribution and a much reduced
intensity (Figure 3.8).
We subjected the same POD21 thrombus slides imaged by NLOM, which does
not alter tissues, to immunoprobing with anti-α-SMA antibody, and all slides contained
positive cells suggestive of myofibroblast differentiation. Interestingly, neointimal
lesions also stain broadly positive for α-SMA, consistent with the notion that neointimal
lesions originate from the myofibroblast-mediated process of thrombus resolution. In
these mature lesions, Movat pentachrome identifies more uniform matrix composition in
neointima from each of the two genotypes, although extracellular blue shading implies
that Col3a1+/+ segments contain a more mucinous matrix, while more yellow coloring
indicates that Col3a1+/- segments contain a more collagenous matrix (Figure 3.8).

91

Figure 3.8. Qualitative analysis of matrix produced by resident myofibroblasts in
resolving thrombi and in mature neointimal lesions at 21 days post-injury. Slides are
presented in distal-to-proximal orientation from top-to-bottom of the figure. On
hematoxylin and eosin stain (H&E), wild-type and mutant arteries appear similar.
However, Movat pentachrome exposes differential matrix synthesis in thrombus and
neointima. Red denotes muscular fibers, blue denotes ground substance, and yellow
denotes collagen. Wild-type thrombus exhibits ground substance localized centrally,
while collagenous patches are restricted to the periphery, which was confirmed by
enhanced second harmonic generation (SHG) intensity (red pseudo-color) produced by
collagen in the periphery and attenuation of signal near the recanalizing lumen. Matrix in
type III collagen-deficient thrombus is more diffusely yellow on Movat and lacks the
well-delineated fibers on SHG signal seen in wild-type thrombus. In more mature
neointima, Movat staining of wild-type matrix is diffusely blue, while collagen IIIdeficient matrix is diffusely yellow. Insets at 100x compare differential matrix stains
side-by-side. White box on SHG signal in collagen III-deficient neointima highlights
paradoxically enhanced intensity of collagen fibers circling the lumen. Positive staining
for α-SMA in all slides confirms that tissue within the limits of the internal elastic lamina
is synthesized by fibromuscular cells, suggesting that these newly formed tissues share a
common cellular origin. Note that the most intense α-SMA staining in wild-type
thrombus occurred in a pattern opposite to that of collagen signal by SHG and Movat
stain.
To investigate the qualitative evidence on Movat that mutant cells produce a
more collagenous matrix by the time thrombus resolution matures into neointima, we
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again imaged neointimal lesions with NLOM to specifically visualize collagen
organization in relation to genotype. Signal interference from the expectedly high
collagen content in adventitia drowns out SHG in the neointima somewhat, but a
relatively intense signal is detectable in a band pattern of undulating and honeycombing
collagen fibers circumscribing the lumen in both genotypes, although to a greater degree
in Col3a1+/- lesions. This honeycombing pattern of matrix within the neointima by late
timepoints has been described previously53.

Quantification of nonlinear optical microscopy signal reveals significantly higher mean
intensity of collagen signal in Col3a1+/- neointima and wider variance in fiber width.
To test the hypothesis that impaired production of type III collagen leads to
disproportionately high overall collagen accumulation in neointimal scars, we imaged
apical neointimal lesions chosen from the arteries of 5 Col3a1+/+ and 6 Col3a1+/- mice.
We restricted the field of view of the NLOM software to the neointima, thereby
excluding any saturating interference from adventitia, while applying the same field to
each segment. Even within any given neointima, the tissue displayed regional variation
in signal intensity. We captured multiple images from each section (N = 31 Col3a1+/+,
57 Col3a1+/- total images), semi-randomly positioning the field to sample all quadrants
of neointimal tissue.
From each of the captured images, we applied a region of interest mask over the
neointima to derive a mean neointimal SHG intensity, which we then normalized to the
intensity derived from a mask including only a portion of the internal elastic lamina
(Figure 3.9A). Immunohistochemical analysis of type III collagen has produced no
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Figure 3.9. Type I collagen content within neointimal lesions negatively
correlates with Col3a1 gene dose. (A) NLOM microscopy (FOV 1) was used to
visualize fibrillar collagen within mature neointimal lesions and intensities quantified
by normalizing mean SHG intensity within the region of interest to mean intensity
derived from a segment of the internal elastic lamina. (B) Intensity ratios were plotted
from each image to depict regional variation within lesions observed at high power.
Normalized SHG generated by mutant neointima was significantly more intense that
that in wild-type tissue, and wider spread of values suggests greater variation in fibril
diameter in mutant lesions. (C) Immunostaining for type I collagen produced a
honeycomb-shaped signal identical to SHG images, which was limited to the
neointima and absent in the arterial media, confirming that mature neointimal collagen
largely consists of type I fibers.
positive stains within mature neointimal lesions in our hands (data not shown). Thus, to
determine whether SHG signal at POD21 neointima was generated from type I collagen,
we immunoprobed arterial sections containing prominent neointima, which showed
positivity in the identical honeycombing pattern described above. Notably, this signal
was limited to the neointima and did not extend into the arterial media, suggesting
differential behavior in response to injury between the two tissues (Figure 3.9C).
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By comparing the mean collagen/elastin signal ratios from the pooled images for
each genotype, we confirmed a significantly increased mean intensity in Col3a1+/neointimal lesions (Figure 3.9B, p = .0408) and a trend toward wider variance in mutant
lesions (p = .0668). The algorithm from which NLOM signal intensity is derived
produces higher intensities both from more numerous fibrils and from thicker collagen
fibrils, so these data are consistent with multiple descriptions of increased mean
thickness of collagen fibrils, as well as greater variability in fibril thickness, both in
Col3a1 knockout mice15 and in human vascular Ehlers-Danlos syndrome patients9.

Impaired synthesis of type III collagen in the proliferative phase of thrombus resolution
is associated with early increases in SHG.
As the dramatic increase in proportional type III collagen content occurs
temporarily during granulation tissue formation and is subsequently resorbed with
maturation of wound healing76, we sought to detect type III collagen production in
tissues from our POD14 cohort of index slides displaying morphology resembling
proliferating and expanding granulation tissue. It was at this timepoint that type III
collagen-deficient arteries first began to show significantly increased incidence of
neoangiogenesis, so we sought to more clearly associate differential type III collagen
production in the expanding matrix with pathological changes.
In wild-type vascular granulation tissue at 14 days after injury, type III collagen
production was abundant by immunohistochemical probe. By comparison,
haploinsufficient tissues conspicuously lacked type III collagen within their matrix,
despite similar appearance to wild-type tissues on H&E stain. NLOM of slides from the
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same POD14 cohort demonstrated an opposite effect of type III collagen deficiency on
the intensity of SHG. Normalized collagen/elastin SHG in resolving thrombi was
greater in mean intensity in Col3a1 mutant tissues as compared to wild-type tissues
(0.6615±0.31 vs. 0.4505±0.14; N = 5 Col3a1+/+, 5 Col3a1+/- sections), which is even
more striking considering that little of the signal was generated by type III collagen.
However, differences in intensity were underpowered and not significant (p = .2063).

Figure 3.10. Type III collagen content and SHG collagen signal in vascular
granulation tissue 14 days after injury. Resolving thrombi that resemble granulation
tissue in wild-type arteries express abundant type III collagen, in comparison to Col3a1+/tissues. A counterstain was not applied in order to allow for unambiguous signal
differences between genotypes. SHG from NLOM investigation of artery sections
paradoxically reveal increased signal for collagen in Col3a1+/- thrombi, suggesting that
signal was generated largely by type I collagen. Note that SHG appears more in a diffuse
field in all sections at POD14, in contrast to more discrete fibers observed at POD21.
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Impaired synthesis of type III collagen during the remodeling of three-dimensional fibrin
gels alters the mechanism of gel compaction following TGF-β1 stimulation.
To clarify the effects of delayed secretion of type III collagen on wound healing,
especially in the context of thrombus resolution, we chose an in vitro model exploiting
primary fibroblast cell lines seeded within three-dimensional stabilized fibrin lattices
tethered to the tissue culture dish as a gelled hemisphere. Once the cultures gelate, the
cells are stimulated with TGF-β1 (10 ng/ml) to simulate the conditions of fibroblasts
recruited into platelet- and/or inflammatory cell-rich thrombi. Over time, the evolution
of tensional forces that develop as these cells remodel the fibrin matrix provide further
stimulation. Furthermore, not only does the fibrin gel construct better model a primitive
thrombus than a collagen gel and stimulate Col3a1 expression102, it also allows for
unambiguous observation of synthesis and rearrangement of new collagen by NLOM
imaging.
We compared dermal fibroblasts isolated from human patients with COL3A1
missense mutations of various impact on fibroblast secretion of type III collagen9 with
those from age-matched controls, as well as murine fetal dermal fibroblasts isolated at
E18 from Col3a1+/+, Col3a1+/-, and Col3a1-/- littermates. All cell lines successfully
contract the volume of their gel matrix from a hemisphere to a flattened disc by 24h and
are grossly indistinguishable. Gels were fixed after 1d, 3d, 7d, and 14d and imaged by
NLOM for TPF and SHG to observe the production and organization of fibrillar collagen
by local cells over time. By day 3, only the slightest traces of collagen were visible,
mostly in control, type III collagen sufficient cell lines (data not shown). However,
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collagen was clearly visible in all cultures by day 7, and emerging differences in the
accumulated levels and structural configuration of that collagen were most obvious by
day 14.
In the control, type III collagen sufficient cultures, both in normal human and
Col3a1+/+ cells, resident fibroblasts secreted collagen at levels generating a more intense
signal than levels produced by mutant cells. In fact, the intensity of signals generated by
fibrillar collagen appears to decrease with the increasing severity of mutations in
COL3A1 in human cells (as mutations nearest to the C-terminus are associated with
lower type III collagen secretion; Figures 3.11 and 3.12) and decrease with reducing
gene dose of Col3a1 in mouse cells (data not shown). Although fibrillar collagen
includes both type I and type III collagen, the magnitude of signal differences between
mutant and control cultures suggests a suppressive effect by mutations on the production
of type I collagen, above and beyond their more direct effects on the secretion of type III
collagen (Figures 3.11 and 3.12).
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Figure 3.11. Remodeling of newly synthesized collagen as a function of COL3A1
genotype after 7 days in three-dimensional culture. By 7 days, control cells have
already organized radiations producing more intense collagen matrix SHG signal,
which extend outward in a network from compact cell bodies. Human vEDS patient
cells display initial formation of radiations in genotypes less detrimental to type III
collagen secretion (G769R and G832R), but cell bodies are more extended and
spindled and seemingly more numerous as severity of genotype/phenotype correlation
increases, seen at the most extreme in G1021R cultures.
Furthermore, resident cells appear to have arranged the collagen fibers present in
cultures at day 7 and day 14 differently as a function of relative type III collagen
production. Control cells extend radiations of collagen fibers outward from their
relatively compact cell bodies, while cultures harboring the most severe mutations
(G1021R) only contain collagen fibers thinly sheathing lengthy, extended cell bodies
and processes. Remaining cultures occupy this structural spectrum from compact
cells/radiating collagen to extended cells/collagen sheaths as a function of their
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genetically-mediated rate of secretion of new type III collagen into the matrix over time
(Figures 3.11 and 3.12).

Figure 3.12. Remodeling of newly synthesized collagen as a function of COL3A1
genotype after 14 days in three-dimensional culture. By 14 days, organized
radiations produced by control cells become thicker and more numerous per cell,
increasing intensity of SHG signal. Human vEDS patient cells display further
thickening of radiations and cell body compaction in a spectrum varying by
genotype/phenotype correlation with rate of type III collagen secretion (top to bottom).
In the most severely affected and most type III collagen-deficient cultures (G832R and
G1021R), cells form only meager radiations, and most signal remains localized in a
sheath around more numerous cell bodies and extended bipolar processes.

Impaired synthesis of type III collagen during the remodeling of three-dimensional fibrin
gels inhibits transcription of COL3A1, COL1A1, and COL1A2 but disinhibits
transcription of ACTA2.
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Quantitative PCR analysis assayed the relative transcription of genes responsible
for the major fibrillar collagens in the extracellular matrix, COL3A1, COL1A1, and
COL1A2, as the seeded cells remodeled the three-dimensional construct over time. In
addition, we assayed transcription of ACTA2, which encodes the α-SMA protein most
responsible for myofibroblast cellular contraction. Results demonstrate significantly
upregulated message levels of ACTA2 by days 3 and 7 in the cultures remodeled by cells
with the most severe genetic impediment (G1021R) to type III collagen secretion (Figure
3.13). On the other hand, vEDS patient cells express lower message levels of genes
encoding type I collagen compared to control cells, which was significant for both
patient cell lines at days 3 and/or 7 for COL1A2 expression but not for COL1A1.
Surprisingly, vEDS patient cells also expressed significantly lower levels of COL3A1 at
days 3 and 7, as missense mutations in COL3A1 perturb type III collagen secretion
downstream of transcription and pose no threat to transcription efficiency (Figure 3.13).
On the other hand, myofibroblasts from all lines display similar expression
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Figure 3.13. Expression of genes controlling new collagen synthesis and
contraction of three-dimensional matrix in cultures of myofibroblasts following
TGF-β1 stimulation. Myofibroblast cultures from vEDS patient cell lines show
significantly less upregulated expression of genes encoding fibrillar extracellular
matrix proteins (COL3A1 and COL1A2) by days 3 and 7, compared to normal control
myofibroblasts, but the most severe mutation (G1021R) in patient cells confers
significantly upregulated ACTA2 expression by the same timepoints, compared with
control cultures. **, p < .01; ***, p < .001.
of genes necessary for production of α1β1 and α2β1 integrin receptors that mediate
outside-in signal transduction from the matrix, in particular via ligand binding by unique
motifs present on type III collagen119, and display similar expression of TGFB1
necessary for further secretion of TGF-β1 into the matrix. One exception to this is the
highly significant increased upregulation of ITGA2 (p < .001) 1 day after stimulation by
cells with an intermediately severe genotype (G769R). Otherwise, expression of TGFB1
and ITGA2 similarly increases after 1 day but again returns to baseline by day 3 and
remains there at day 7 in all cells. Expression of ITGA1 and ITGB1 commonly and
steadily increases among all cell lines (Figure 3.14).
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Figure 3.14. Expression of genes encoding proteins that mediate outside-in
matrix signal transduction in response to TGF-β1 stimulation. Patient cells
upregulate genes encoding TGF-β1 and α1β1 and α2β1 integrins known to interact
with binding sites on type III collagen similarly to upregulation by normal control
cells, with the exception of highly significant enhanced expression of ITGA2 by
G769R cells at day 1. ***, p < .001.
Lastly, expression of genes encoding matrix-digesting enzymes collagenase
(MMP-1) and matrix metalloproteinase-9 (MMP-9) robustly increases at day 1 in
response to TGF-β1 but occurs similarly within all cell cultures, while expression of the
gene encoding matrix metalloproteinase-2 (MMP-2) remains negligible (Figure 3.15).
Data from cultures of mouse fetal dermal fibroblasts showed similar trends in
expression to the human myofibroblast cultures above, although differential expression
by mutant genotypes was not significant. One notable exception to this was the
replication of significantly increased (p < .05) expression of Itga2 by Col3a1+/myofibroblasts, cells harboring an intermediate Col3a1 gene dose, 1 day after TGF-β1
stimulation (data not shown).
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Figure 3.15. Expression of genes encoding matrix-digesting enzymes in response
to TGF-β1 stimulation. All lines similarly demonstrate robust upregulation of
MMP1 and MMP9 at day 1 after TGF-β1 stimulation before returning to baseline at
day 3, while expression of MMP2 remains flat throughout.

Discussion
We noted previously that neointimal lesions when present were always situated
at or just beyond the poles of resolving thrombi, which, on the basis of the migrating
wave-like progression of thrombus resolution, suggests that they represent the most
mature phase of arterial wound healing. Thus, they resemble a residual cutaneous scar
and likely possess the collagenous matrix most maturely organized since the eliciting
injury. Here we present evidence that formation of a mature neointimal scar in type III
collagen-deficient arteries in response to injury involves production of deranged
collagen by resident myofibroblasts (Figure 3.9). Furthermore, this derangement occurs
within the timeframe that collagen acquires a more ordered structure through active
remodeling by these fibroblasts, which is apparent when comparing the discrete fibrous
shape of SHG signal at POD21 to the more diffusely distributed signal at POD14 (Figure
3.10). Although it is not explicitly clear that an increased mean intensity of SHG as
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measured by NLOM is directly proportional to increased collagen mass within the tissue,
the relationship between signal and individual fiber diameter implies a higher mean
diameter of collagen fibrils and a wider variance in diameters. This is consistent with a
defining feature of fibrosis: disorganized and highly-crosslinked collagen deposition120.
The discrepancy between SHG signal produced by type III collagen-deficient
tissues, where signal is enhanced, and that produced by type III collagen-deficient cell
cultures, where signal is lacking, likely results from the difference in relative density of
myofibroblasts involved between the remodeling of the tissue and remodeling of the gel
construct. Again, timing is everything. Neointimas in Col3a1+/- tissues are organized at
late timepoints, after 21 days, by cells derived from those in preceding thrombi, which
we have shown to contain a significantly abnormal density of proliferating
myofibroblasts when compared with wild-type thrombi (Figure 2.19). Experimental
constructs of type III collagen-deficient gels instead begin with the same number of cells
as wild-type control gels and were only followed for 14 days.
In addition, increased α-SMA expression, as would occur from in increased
number of actively contracting myofibroblasts, directly correlates with increased
contractile tension within a remodeled tissue95, and sustained tension further upregulates
α-SMA expression90,91. Thus, the lack of sufficient ramping of tension could explain the
failure to elicit differential expression of Acta2 or matrix genes in mouse gel constructs
at late timepoints, when gels contained less than half the number of myofibroblasts that
were seeded into human cultures. In fact, significantly increased early Itga2 expression
by cells with intermediately severe mutations at early timepoints was preserved between
species.
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As suggested by our quantitative PCR results from human cultures, on the other
hand, mechano-sensitive feedback from growing tension in the matrix is one of the
driving forces behind transcriptional regulation of collagen production. Cells from all
genotypes generally show similar TGF-β1-mediated early transcription events in the first
day of culture, before ACTA2 expression even begins to rise (Figures 3.13, 3.14, and
3.15). However, events occurring between 3 and 7 days, long after the original TGF-β1
pulse, involve deposition and organization of new insoluble extracellular matrix, as
observed in NLOM images from remodeling gels (Figures 2.11 and 3.12). It is the
feedback from deposition and reorganizing activity by cells in this time period that
correlates with the emergence of differential transcription of genes encoding matrix
proteins by mutant cultures (Figure 3.13).
The effect of tension and collagen accumulation on transcriptional regulation of
matrix production was most obvious in the regulation of COL3A1 expression by human
myofibroblasts. Unlike mutant cells from mice, where haploinsufficiency of the allele
determines a maximum rate of transcription at half the rate of wild-type cells, missense
mutations in humans do not impede initial transcription but only the maximum rate of
post-translational secretion of structurally altered proteins from the endoplasmic
reticulum. So the fact that we observe differential expression of COL3A1 at late
timepoints as a function of genotype in human cultures suggests that COL3A1
expression is sensitive to feedback dependent on the rate of secretion of new type III
collagen.
In vitro experiments generating copolymers of type I and type III collagen have
determined that the relative content of each at the time of fibrillogenesis determines the
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rate of fibril extension, the diameter of resulting fibrils, and the flexibility of those
fibrils105, so it is likely that sluggish production of new type III collagen alters the
material properties of the total matrix produced, possibly providing some type of
feedback to suppress the further upregulation of COL3A1 and COL1A2 and promote the
compensatory upregulation of ACTA2 (Figure 3.13).
Some hint of such a mechanism comes from the concept of stress-shielding in
mature connective tissue, where cells are shielded from external loads on the tissue by
the mechanical properties of the organized matrix they construct. That is, even after an
original matrix volume has been compacted into a higher density, the cells themselves
no longer have to bear the load of resisting tension their own cellular contraction94. This
could explain the simultaneously compact bodies of control cells in NLOM images and
the plateau reached in ACTA2 expression after 7 days in culture (Figures 3.11 and 3.13).
Images of mutant cultures, on the other hand, demonstrate an inability of cells
within a type III collagen deficient matrix to construct a stress-shielding connective
tissue on the same timecourse as normal, type III collagen sufficient cultures, such that
burden of tensional loads may instead fall on the contractile myofibroblasts themselves
and on the energy required to maintain that contraction for a longer period of time. This
prediction of increased reliance on contraction is borne out by images of extended
myofibroblasts in the absence of a matrix shield and the simultaneous excess in ACTA2
expression observed in these cultures after 7 days (Figures 3.11 and 3.13). Rather than
waste the energy of indefinite contraction, a programming switch to forego present
matrix production to instead initiate proliferation and generate more cellular actors
within the tissue before reattempting matrix production could be yet another way that
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mutant cells cope with an untenable tensional load. If this cycle continuous without cells
ever achieving stress-shielding of tension due to the inflexible matrix they inevitably
produce, a fibroproliferative contracture could plausibly result94.
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Chapter 4: Altering the Course of Thrombus Resolution Alters the Incidence of
Vascular Defects Following Injury
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Introduction
In-Stent Restenosis and the Development of Drug-Eluting Stents
With the advent of endovascular interventions to restore patency of arteries
occluded by arterial diseases like atherosclerosis, the development of restenosis of the
lumen following balloon angioplasty or stent placement poses a substantial impediment
to successfully alleviating ischemia121, despite however much thickening adaptively
decreases stress on injured walls. Stents improve upon angioplasty through the device's
permanent geometric resistance to diameter-reducing remodeling of the arterial media, a
homeostatic response to decreased flow as discussed in Chapter 2. However, restenosis
as a consequence of neointimal hyperplasia persists, affecting virtually all treated
patients, with 7% suffering total occlusion and 30% suffering partial "proliferative"
occlusion that extends beyond the axial length of the stent122.
Cytostatic strategies to reduce the activation and proliferation of neointimal cells
in response to vascular injury and inflammatory stimuli thus include the local
administration of rapamycin (also known as sirolimus) by coated stents, in theory to
replicate rapamycin's in vitro check of vascular SMC S phase entry by maintaining
levels of p27Kip1 cyclin-dependent kinase inhibitor. At 3 and 7 days after placement of
stents, local rapamycin delivery led to lower protein levels in whole vessel lysates of the
proliferative markers proliferating cell nuclear antigen (PCNA) and phosphorylated
retinoblastoma protein (pRb) by 60% and 50%, respectively, and higher levels of
p27Kip1. By 28 days, use of sirolimus corresponded with a ~50% reduction in stenosis in
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both pigs and humans on histological images in comparison to arteries stented with bare
metal84,121,123-125 (Figure 4.1).

Figure 4.1. Low- and high-power photomicrographs 28 days after oversized stent
placement in normal porcine coronary arteries. A and B (high power) are a bare metal
stent with neointimal formation typical for degree of strut-induced medial injury. C,
Rapamycin-coated stent has significantly less neointima vs. bare metal stent despite a
similar degree of vessel injury. High-power photomicrograph of rapamycin-eluting
stent (D) demonstrates neointima consisting of SMCs and proteoglycans. Notice strutinduced focal medial compression without medial necrosis or intimal hemorrhage.
Reprinted with permission from Wolters Kluwer Health [Stent-based delivery of
sirolimus reduces neointimal formation in a porcine coronary model. Suzuki T, Kopia
G, Hayashi S, et al. Circulation. 2001].
However, attributing these results to such a straightforward antiproliferative
mechanism deserves reconsideration. We presented evidence in Chapters 2 and 3 that
the development of neointimal lesions requires and emerges as only the final stage of
several in the process of thrombus resolution and vascular wound healing. Studies of
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neointimal thickening following rapamycin, like those above, have largely failed to fully
investigate the link to early thrombosis-related events, instead relating molecular
analyses at early timepoints to histological morphometry at later timepoints and
incorrectly assuming that these metrics gauge an identical and linear outside-in
proliferative process84,123. It is possible that rapamycin may not directly inhibit the
proliferation of neointimal cells as surmised but may instead fundamentally alter the
course of critical upstream inflammatory events.

Rapamycin as an Immunomodulator
Rapamycin/sirolimus is a natural product macrolide extracted from
microorganisms in the soil of Easter Island (site of the extinct Rapanui civilization). It
was originally celebrated as an immunosuppressant preventing acute rejection of
transplantated allografts on par with cyclosporin and tacrolimus, which impede T cell
activation and subsequent proliferation by specifically inhibiting calcineurin-dependent
transcriptional upregulation of cytokines like IL-2 and their receptors126, 127. However,
rapamycin, though similar in macrolide structure to tacrolimus, has no effect on cytokine
production but instead alters intracellular signaling elicited by IL-2 receptor agonism to
block T cell proliferation. Rapamycin arrests the G1-to-S-phase progression by
interrupting the decline of p27Kip1 and rise of p21Cip1 cyclin-dependent kinase inhibitors
as above, but this inhibitory effect is not limited to T cells or even to IL-2 signaling but
likely extends to growth-factor-mediated cell behavior more generally127,128.
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Figure 4.2. Signaling events activating Akt and cellular functions regulated by Akt.
Reprinted with permission from Cold Spring Harbor Laboratory Press [PI3K-PKB/Akt
Pathway. Hemmings BA, Restuccia DF. Cold Spring Harbor Perspectives in Biology.
2012].
Rapamycin mediates its effects on signaling by inhibiting the kinase activity of
mammalian target of rapaymycin (mTOR) within the broader context of the PI3K/Akt
pathway (Figure 4.2), which helps explain its pleiotropic effects. The diversity of cell
functions regulated via the highly conserved PI3K/Akt signaling cascade includes
proliferation, survival, growth, metabolism, migration, and angiogenesis, earning a
massive amount of attention from researchers, and rapamycin is a useful tool for
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studying the mTOR-dependent wing of this pathway129-131. Not surprisingly considering
this spectrum of behaviors, much of the discussion has been stimulated by the
preponderance of cancer-associated mutations that impinge on this pathway, and
rapamycin and its derivatives have even been auditioned as anti-neoplastic agents132.
However, just as unchecked cell proliferation is necessary but not sufficient for
carcinogenesis, the cell behavior targets of rapamycin include but are by no means
limited to cell proliferation. Although rapamycin prevents IL-2-mediated T cell
proliferation and acute cell-mediated allograft rejection much like cyclosporin, it also
clearly outperforms cyclosporin in preventing chronic allograft rejection. Chronic
rejection, unlike acute rejection, occurs through: 1) increasingly antibody- and activated
macrophage-mediated inflammatory mechanisms, 2) the familiar occlusive vascular
pathology of neointimal hyperplasia, and 3) interstitial fibrosis of the graft. So it appears
that a broader mechanism extending beyond antiproliferative effects may account for the
efficacy of rapamycin in attenuating both late rejection and neointimal hyperplasia133-136.
Transplant biology offers an excellent disease model linking the chronic
dysregulation of wound healing and fibroproliferative pathology described in Chapter 3
with problematic vascular remodeling. For our purposes here, it especially highlights
the primary initiating roles of inflammatory cell migration into and chronic stimulation
from within a new tissue, without negating a role for cell proliferation137. An elegant
study transplanting mouse carotid arteries into the circulation of recipients deficient for
various chronic inflammatory scenarios (i.e, no acquired immunity at all, no B cells or
humoral immunity, no CD4+ T cells, or no macrophages) showed that each of these
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models completely fails to develop neointimal thickening, unlike control recipients of
the same background strain138 (Figure 4.3).

Figure 4.3. Selected sections from mouse carotid artery loops allografted into strains
whose immunologic features are described in the panels. The neointima extends
between the internal elastic lamina (Verhoeff's elastin stain) and the vessel lumen
(between arrows in B-J; there is no neointima in A). (A) Rag2-/-, (B) µMT-/-, (C) CD4-/-,
(D) B6129F2/J control for A-C. (E) MHC II-/-, (F) MHC I-/-, (G) bg3/bg3, (H)
C57BL/6J control for E-G. (I) op/op, (J) op/+ control for op/op. Reprinted with
permission from the National Academy of Sciences of the United States of America
[Immunologic basis of transplant-associated arteriosclerosis. Shi C, Lee W-S, He Q, et
al. Proceedings of the National Academy of Sciences. 1996].
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It follows that rapamycin could produce similar effects, as the PI3K/Akt pathway
regulates chemotaxis and migration139,140. In fact, rapamycin potently inhibits
chemotaxis and chemokinesis of phagocytic neutrophils in response to granulocytemacrophage colony-stimulating factor141. Everolimus, an mTOR inhibitor derived from
rapamycin for oral administration, similarly prevents both transplant vasculopathy in
human patients and stent restenosis in atheroma-prone animal models. This prompted
investigators to determine that it broadly inhibits human macrophage chemotaxis toward
monocyte chemoattractant protein-1 and multiple other attractants in vitro142. Only
minimal evidence from transplant studies extends rapamycin's blunting of chemotaxis to
macrophages143, but rapamycin clearly impedes macrophage phagocytosis of antibodycoated structures, most likely through inhibition of mTOR/p70S6 kinase-dependent
organization of cytoskeletal actin144.
Regardless, studies of neointimal thickening in p27Kip1-/- mice following direct
mechanical injury to femoral arteries have already identified excessive infiltration of
bone marrow-derived inflammatory cells, not fibrocellular proliferation, as the primary
cause. As proof, researchers determined that bone marrow transplant from p27 Kip1-/donors prior to injury was sufficient to confer neointimal thickening onto wild-type
mice. However, occlusive fibrocellular hyperplasia in p27Kip1-/- recipients of wild-type
and p27Kip1-/- bone marrow still exceeded all other groups, suggesting that the
unchecked proliferation of non-hematopoietic cells migrating into the intima
downstream of inflammatory signals was also involved145. Thus, the most parsimonious
interpretation of the fact that rapamycin elevates cellular p27Kip1 is that, where
neointimal hyperplasia progresses as an extension of vascular wound healing, the
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suppressive effect of rapamycin more likely hinges on its suppression of early
inflammatory cell migration, long before it can act by suppressing the proliferation of
secondarily-arriving neointimal cells. The distinction is crucial, if vascular wound
healing depends as much on a thrombotic nidus for inflammatory stimulation as our data
would suggest, because rapamycin's protective effect against neointimal formation may
simultaneously be its deadly effect against thrombus resolution.

Impairment of Wound Healing by Rapamycin
A blunting of inflammatory infiltrate by rapamycin is consistent with extensive
evidence that rapamycin pathologically impairs wound healing, as successful wound
healing requires macrophage infiltration (see Chapter 2). This has, not incidentally,
limited rapamycin's clinical usefulness. Following transplantation in humans, rapamycin
has been associated with severe complications like venous thromboembolism,
dehiscence of graft anastomoses or sternal closures, gastroduodenal ulcers and
hemorrhage, and deep surgical wound infections, among others146,147,148.
Rapamycin-eluting stents significantly reduce restenosis when compared to baremetal stents, as measured both by angiographic metrics and incidence of repeat invasive
revascularization, for the first 9 months following percutaneous coronary intervention149,
earning approval by the Federal Drug Administration and widespread adoption into
clinical practice. However, subsequent clinical practice also allowed broader
perspectives on outcomes from much larger treatment cohorts (N = 8146 and 6033 vs. N
= 1058) over a longer period of time (3 years vs. 270 days), revealing an unexpected
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number of recipient patients who paradoxically survive without restenosis only to die
from late stent thrombosis150 (Figure 4.4). These events are rare but as devastating as the
disease they are meant to prevent, and the risk of death from drug-eluting stents (coated

Figure 4.4. Mechanisms of late stent thrombosis in ostial and bifurcation stenting.
(A to D) Radiograph and histologic sections (Movat pentachrome) from a 77-year
old man who had two stents placed in the native left anterior descending coronary
artery (LAD) for stable angina 450 days before sudden cardiac death. (A)
Radiograph of the LAD with two stents in place, a proximal rapamycin-eluting
(Cypher) and a distal bare-metal stent (NIR). The Cypher stent struts (*) protrude
into the ostium of the left circumflex artery (LCx). (B) Section taken from the
proximal Cypher stent, which is totally occluded by a platelet-rich thrombus while
distally it is patent (C) with minimal neointimal tissue. The NIR stent (D) in the
distal LAD demonstrates 50% in-stent area stenosis consisting of neointimal tissue
composed of smooth muscle cells in a proteoglycan/collagen matrix with absence of
fibrin. Reprinted with permission from Elsevier [Pathology of drug-eluting stents in
humans: delayed healing and late thrombotic risk. Joner M, Finn AV, Farb A, et al.
Journal of the American College of Cardiology. 2006].
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in either rapamycin or paclitaxel, both antiproliferative agents) first significantly exceeds
that for bare-metal stents after 6 months. Risk of thrombosis steadily increases from
there, without sign of diminishing, at the rate of 0.6% per year and occurs unpredictably
despite antiplatelet therapy151,152.
Pathological evaluation of affected arteries at autopsy following fatal thrombosis
show proximal occlusive platelet-rich thrombi but distally patent segments in areas
within rapamycin-eluting stents, while "control" sections in areas within bare-metal
stents demonstrate stenotic but stable neointimal thickening150 (Figure 4.4). Fibrin
deposits were found overlaying struts even in nonoccluded, rapamycin-stented segments
from patients dying from unrelated causes, such that delayed healing prevented any
growth of an endothelialized barrier between the vascular wall and the lumen150 (Figure
4.5).
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Figure 4.5. A 65-year old man suffered traumatic injury to the head resulting in
death. This patient had received two stents in the LAD, a proximal Cypher and a
distal Bx Velocity (bare-metal) 15 months before death, which were found to be
patent at autopsy. (A) (Cypher) and (D) (Bx Velocity) are radiographs of the
stented LAD segment. All sections have been stained with Movat pentachrome.
(B) Histologic section of the Cypher stented artery showing minimal coverage of
the struts by fibrin. (C) High-power magnification showing peri-strut fibrin with
rare endothelial cells but no luminal thrombus, whereas inflammation and smooth
muscle cells are only rarely observed. (E) Section of the Bx Velocity stent. There
is abundant neointimal tissue consisting of smooth muscle cells in a proteoglycan
matrix and an overlying endothelium. (F) High-power section of the boxed area in
E. Lymphocytes are present around the stent strut with minimal fibrin underneath
the strut. The luminal surface of the stent is covered by smooth muscle cells in a
proteoglycan/collagen rich matrix. Reprinted with permission from Elsevier
[Pathology of drug-eluting stents in humans: delayed healing and late thrombotic
risk. Joner M, Finn AV, Farb A, et al. Journal of the American College of
Cardiology. 2006].
The number of struts without an overlying neointimal layer positively correlated
with the number of struts covered by platelet-rich thrombi, suggesting that the neointima
and its endothelial barrier were actually thrombo-protective. Thus, investigators
conclude that, while preventing the neointima from thickening may prevent relative
ischemia due to decreased flow, the total extent of neointimal suppression does not
suffice as a parameter by which success of clinical intervention is based. Total occlusion
of flow by thrombosis more often occurs in the presence of rapamycin, as determined by
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clinical data151,152, and in the absence of endothelial-lined neointima, as determined by
histological analysis, so further refinements to intravascular intervention must balance
these risks64.

Figure 4.6. Low power photomicrographs at 30, 60, 90, and 180 days after placement of
control and rapamycin-eluting stents in porcine coronary arteries. At 30 days, neointimal
area is greater with bare metal (A) as compared to the rapamycin stent (B). At 90 and
180 days, neointimal area and morphology are similar for bare metal (C, 90 days and E,
180 days) and rapamycin stents (D, 90 days and F, 180 days). Metachromatic stain.
Reprinted with permission from Oxford University Press [Long-term effects of polymerbased, slow-release, sirolimus-eluting stents in a porcine coronary model. Carter AJ,
Aggarwal M, Kopia GA, et al. Cardiovascular Research. 2004].
Furthermore, evidence from pig models uncommonly followed out until very late
timepoints (60, 90, and 180 days) belie the fact that rapamycin-eluting stents merely
delay the onset of arterial inflammation and neointimal hyperplasia, eventually achieving
thickness similar to that in bare-metal stents. Neointima developed in response to bare
metal stents, on the other hand, had stabilized in thickness by these late timepoints.
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Most surprisingly, at these late timepoints protein levels of cell cycle-inhibiting p27Kip1
and the cycling marker PCNA in whole tissue lysates were elevated in rapamycinstented arteries over bare-stented arteries, either refuting original theories that rapamycin
acts by inhibiting cycling of the resident neointimal cells153,154 (Figure 4.6) and/or
possibly demonstrating a confound of extrapolating neointimal events from whole tissue
samples.
Given the immunostatic properties of rapamycin and its ability to retard wound
healing from progressing beyond the initial inflammatory phase, for the final aim of the
current study we sought to pharmacologically alter the course of thrombus resolution
prior to the functioning of mutant myofibroblasts to confirm the necessity of
dysregulated myofibroblast activity for the development of vascular defects in mutant
arteries. We systemically administered rapamycin to Col3a1+/+ and Col3a1+/- mice
daily for 14 post-operative days following carotid ligation so that we might immobilize
thrombus resolution prior to the myofibroblast-driven proliferative phase. By delaying
the downstream recruitment of and onset of deranged collagen synthesis by Col3a1+/myofibroblasts, we sought to normalize the incidence of medial neovascularization
observed between wild-type and mutant arterial segments at POD21. This would imply
that myofibroblast activity, including production of deranged collagen matrix, is
necessary for the emergence of vascular defects in type III collagen-deficient mice, and
that the appearance of blood-filled vascular channels occurs through the active process
of remodeling following injury rather than as a complication of baseline arterial fragility.
We also hypothesize that prevention of initial thrombus formation may improve
the incidence of medial neovascular defects in the walls of Col3a1+/- arteries and
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possibly identify a therapeutic avenue for vEDS patients. However, our original data
involved the use of ketoprofen for pain control in the first two post-operative days, and
ketoprofen possesses a potent antiplatelet activity equivalent to aspirin155,156,157. Thus,
we opted to investigate the influence of ketoprofen over the incidence of medial defects
at POD21 by repeating carotid ligations but switching pain control methods to the
administration of buprenorphine, an opioid narcotic. We expect that buprenorphine will
further prolong thrombus resolution and exaggerate differences in the incidence of
defects in mutant mice.

Methods
Administration of rapamycin following injury by carotid ligation.
Carotid ligation was performed exactly as described originally in Chapter 2, this
time with 4 Col3a1+/+ mice and 4 Col3a1+/- mice subsequently receiving rapamycin
daily for the first post-operative 14 days. Rapamycin dissolves poorly in aqueous
solution, so powder was dissolved into DMSO at a concentration of 25mg/ml. At the
time of treatment, rapamycin/DMSO solution was freshly diluted 1:10 into PBS just
before subcutaneous injection into the animal, so that the drug could not precipitate out
of the injectate. The resulting injected dose, administered for the first time at 4 hours
after the conclusion of the procedure and daily after that, was a total of 2mg/kg. For
vehicle-treated controls (N = 5 Col3a1+/+ mice; 5 Col3a1+/- mice), animals were
administered an equivalent volume of DMSO based on weight to their counterparts in
the rapamycin-treated arm, which was freshly diluted 1:10 just before injection over an
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identical timecourse. Mice recovered from surgery over a similar timecourse as before,
losing and regaining weight within the first 7 post-operative days without any excessive
rates of death in comparison with mice from the original untreated experiments.
All mice were sacrificed on POD21 and their carotid arteries processed as
described in Chapter 2. Histological analysis, by an identical method of counting the
presence or absence of occlusive thrombus and presence or absence of media-occupying
neovessels for each index slide, was performed. Results between rapamycin- and
vehicle-treated groups from each genotype were analyzed by constructing 2x2
contingency tables and applying Fisher's exact test. Tables were first constructed to
compare effects of genotype under the condition of each treatment, and a second round
of tables was constructed to compare effects of treatment on each of the genotypes.

Administration of buprenorphine following carotid ligation.
In this experiment, 4 Col3a1+/+ mice and 9 Col3a1+/- mice received carotid
ligation, and we merely switched the prescribed analgesic for pre- and post-operative
pain relief in rodents from 5mg/kg ketoprofen (administered as pre-operative analgesia
and twice daily for the first two post-operative days) to 0.1mg/kg buprenorphine
(administered as pre-operative analgesia and twice daily for the first two post-operative
days). All subsequent post-operative care was identical to the original experiments in
Chapter 2, although we observed no animal deaths before scheduled sacrifice at POD21
in this cohort, likely due to superior pain control by buprenorphine. Carotid arteries
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were harvested, processed into index slides, and the resulting pathology analyzed again
identically to methods described in Chapter 2.

Results
Rapamycin treatment profoundly retards thrombus resolution, similarly affecting both
genotypes.

Figure 4.7. Rapamycin profoundly retards thrombus resolution through 21 days in
wild-type mice. At the distal poles of residual thrombus, clotted red blood cells are
streaked only partially by pink, acellular fibrin, although migration of neutrophils,
macrophages, and fibroblasts into fibrin tracts is apparent by inspection of characteristic
morphology of these cell types. As fibrin deposition increases further down the arterial
axis, cell migration intensifies, and invaginating clefts lined by endothelial cells appear.
Further down still, clefts coalesce into centrally recanalized channels. The profuse
cellularity observed previously at POD14 in areas displaying similar morphology from
both genotypes was largely attenuated under the influence of rapamycin.
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Figure 4.8. Rapamycin profoundly retards thrombus resolution through 21
days in type III collagen-deficient mice. At the distal poles of residual thrombus,
clotted red blood cells are matted only partially by pink, acellular fibrin, although
migration of neutrophils, macrophages, and fibroblasts into fibrin swaths is apparent
by inspection of characteristic morphology of these cell types. As fibrin deposition
increases further down the arterial axis, cell migration intensifies, and invaginating
clefts lined by endothelial cells appear. Further down still, occlusive thrombi are
resorbed into the neointima lining the recanalized lumen. The profuse cellularity
observed previously at POD14 in areas displaying similar morphology from both
genotypes was largely attenuated under the influence of rapamycin. However,
unlike the wild-type artery above, neointimal formation still occcurs at the proximal
poles in type III collagen-deficient segments.
By creating a cohort of index slides from rapamycin-treated animals and from
vehicle-treated animals, we found no morphological difference between vehicle-treated
animals and untreated animals from experiments in Chapter 2 (data not shown). Slides
from rapamycin-treated animals, on the other hand, demonstrate vividly altered
morphology that similarly affects all arteries regardless of genotype (Figures 4.7 and
4.8). The most salient feature of a common pathology is the impediment to migration of
all cell types present, including neutrophils with polymorphic nuclei, macrophages with
abundant cytoplasm, and spindled fibroblasts, and the suppression of remodeling despite
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high burdens of inflammatory cells in both groups. As a result, large fields of fibrin
remain unremodeled into a more collagenous matrix, as had been instead seen in more
densely cellular thrombi from untreated artery segments in Chapter 2. However, small
areas of neointimal formation are present at the proximal poles of mutant arteries (Figure
4.8), while wild-type arteries display endothelial lining of fibrinous collars encircling the
lumen (Figure 4.7). This feature was previously described in wild-type arteries at
POD14 just distal to proper neointimal formation (Figure 2.16), so it appears to be a
precursor lesion to neointimal hyperplasia. Here, the dropout of fibrinous material from
the collar in sections of Figure 4.7 is due to artifact introduced during serial sectioning,
as the material was likely not sturdy enough to stand up to the microtome blade.

Rapamycin treatment equalizes the incidence of neovessels occupying the arterial media.

Table 4.1. Rapamycin significantly increases thrombus burden in both genotypes
but equalizes the incidence of neovascularizatioin.
The most obvious and consistent similarities between all arterial segments
regardless of genotype is the heavy burden of occlusive thrombus and the striking
simultaneous absence of vascular channels penetrating the arterial media. By statistical
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analysis of arterial segments, no differences were detected in the number of segments
containing unresolved thormbi between the genotypes under rapamycin treatment (p =
.2869), and no differences were detected in the number of segments containing mediapenetrating neovessels (p = 1.000; Table 4.1). On the other hand, statistical analysis of
segments from vehicle-treated mice replicated the higher incidence of neovessels in
mutant artery segments (although the analysis was underpowered and not statistically
significant, p = .0644) without convincingly replicating the higher thrombus burden in
mutant segments compared to wild-type segments (p = .5403).
However, by comparing artery segments from rapamycin-treated animals to
those from vehicle-treated animals reveals an extremely significant increase in occlusive
thrombus burden affecting both genotypes equally (p = .0001 in both cases).
Nonetheless, rapamycin has no effect on the relative absence of neovessels observed in
wild-type segments but confers a clear trend in the reduction of neovessels in mutant
segments (p = .0961).

Buprenorphine increases incidence of thrombus and neovessels in wild-type artery
segments but attenuates them in mutant artery segments following carotid ligation.
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Table 4.2. Buprenorphine transfers the predisposition for thrombosis from mutant
artery segments to wild-type artery segments, equalizing the risk for
neovascularization.
Despite our hypothesis that buprenorphine would exaggerate residual thrombus
burden in Col3a1+/- artery segments, we instead found that narcotic analgesics improved
the resolution of thrombus and the incidence of neovessels in comparison with
ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) acting nonselectively on
the cyclo-oxygenase-mediated production of prostaglandin E2. On the other hand,
ketoprofen appeared to be protective against residual thrombus burden and
neovascularization in wild-type artery segments (Table 4.2).

Discussion
The discrepancy between statistically ambiguous thrombus burden in arteries
from vehicle-treated mutant animals (p = .5403) and differential thrombus burden in
mutant arteries from the original data (p = .0289) reflects that thrombus burden has not
been as thoroughly sampled here as in Chapter 2. However, the data available here,
where artery segments are already numerous enough to come very close to achieving
statistical significance for the increased incidence of neovessels in mutant arteries (p =
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.0644) supports the hypothesis that the thrombus itself does not attract circumstances
promoting neoangiogenesis. Rather, the properties of the specifically altered matrix
produced by type III collagen-deficient cells seem to be necessary for pathologic
neovascularization.
Otherwise, rapamycin successfully neutralizes neovascularization in all arteries
following injury, regardless of genotype. However, the equally undesirable result of
significantly enhanced burden of unresolved thrombus in arteries regardless of genotype
is not a suitable therapeutic tradeoff. This result is consistent with clinical experience
that rapamycin-eluting stents promote occlusive thrombosis, even in altered flow states
far less dramatic than induced here151,152. At the same time, our pathological slide series
demonstrates that rapamcyin severely retards thrombus resolution but does not neutralize
it entirely, as neointimal lesions still form in arteries from treated animals, albeit at
thicknesses smaller than those seen previously in Chapter 2. These data are consistent
with longer-term animal studies showing that rapamycin only delays the progression of
neointimal hyperplasia, which eventually reaches thicknesses on par with injured arteries
in untreated animals153. This calls into question the therapeutic benefit of drug-eluting
stents vs. bare-metal stents, when drug-eluting stents may improve stenosis by
radiographic measurements but do not necessarily improve long-term survival by
impeding resolution of fibrin deposits and increasing risk for snowballing occlusive
thrombogenesis.
One interesting note from the literature examining the usefulness of rapamycineluting stents is the polarized regard by which different researchers approach the study
of neointimal proliferation. Studies celebrating rapamycin's prevention of neointimal
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hyperplasia discuss stenosis from neointimal formation as clear-cut pathology to be
reduced84,121,123-125, while studies implicating rapamycin for the increased risk of
thrombogenesis decry the impaired healing64,150,158, as defined by a lack of neointimal
coverage growing over stent struts. It is interesting to consider why neointimal
thickening occurs in the first place in response to injury, considering the vascular
mechanics afforded by wall thickening and by the material properties afforded by
circumferential matrix remodeling within the new tissue, as we have observed using
NLOM. Obviously a balance between essential healing and girding of injured structures
with sufficient patency of the lumen to maintain appropriate blood flow to downstream
organs is more desirable than either extreme. The data presented by this project, by
linking immunity- and myofibroblast-mediated thrombus resolution, neointimal
formation, and matrix production, provides a new paradigm within which to optimize
therapeutic regulation of arterial wound healing.
In regards to our trial of buprenorphine in comparison with earlier experiments
utilizing ketoprofen, it appears that its antiplatelet effects may outweigh the antiinflammatory effects within wild-type arteries following injury, decreasing the extent of
thrombus generation and extension and thus preventing succeeding thrombus resolution.
In mutant arteries, however, a baseline predisposition to impaired thrombus resolution
and tendency even for excessive thrombus growth and extension likely overcomes any
benefit from reduced initial thrombus nidus. Instead, ketoprofen's anti-inflammatory
effects may impede arterial wound healing even further in an effect smaller than that of
rapamycin but just large enough to blunt the benefits of pro-neovascularization
signalineg by inflammatory cells and extend the presence of neovessels beyond a
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timeframe in which they are useful. This result is important for guidance of patient care,
as arterial injury and progression to clinical complications like dissection in vulnerable
populations often involves a painful component, and use of commonly available
NSAIDs to treat the symptoms of pain may precipitate clinical progression.
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Chapter 5: Discussion
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Figure 5.1. Model of fibroproliferative vascular wound healing resulting from
deficient secretion of type III collagen following injury.
Fibroproliferative vascular wound healing in vEDS patients?
Together, the data presented in this dissertation strongly argue for a pathological
process at work in type III collagen-deficient arteries that more closely resembles
predisposition to fibroproliferative disease following tissue injury than to the inherent
"tissue fragility" often touted to explain the clinical complications of vEDS patients159.
According to our results, thrombus resolution proceeds normally until the proliferative
phase, where recruited myofibroblasts that secrete insufficient levels of type III collagen
generate deranged matrix within an expanding granulation tissue, which then
accumulates greater numbers of macrophages in association with increased
myofibroblast proliferation, expression of contractile α-SMA, and incidence of ectopic
neovascularization. Rather than the tapering of myofibroblast activity and progression
to the final contraction and resolution phase characteristic of normal wound healing, the
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type III collagen-insufficient tissue appears to enter into a smoldering cycle resembling
disorganized and unchecked contracture (Figure 5.1).
This novel model of pathogenesis would reconcile many perplexing clinical
features of the disease, as discussed in Chapter 2, with the vascular mechanics of arterial
wall integrity, as discussed in Chapter 1. The fact that neovessels persistently traverse
the medial layer bears structural significance for wall integrity in that these abnormal
defects threaten to disrupt the normally even distribution of wall stress in elastic arteries
as afforded by their lamellar architecture33. Thus, these channels could increase the risk
of localized structural failure under situational bouts of increased wall stress, possibly
culminating in the blood-filled inter- or intralayer false lumina of arterial dissection or,
worse, complete wall rupture. This possibility is consistent with a predisposition to
dissection or rupture despite only rarely noted premonitory weakening of wall tensile
strength by arterial dilation159, as is more commonly and consistently observed in other
syndromes associated with artery dissection, like Marfan syndrome or Loeys-Dietz
syndrome29. In this way, spontaneous artery rupture or dissection is not spontaneous at
all but more accurately an overexuberant response on the part of tissue to covert injury.
This would also explain the clinical benefit of celiprolol14, which as a betablocker prevents spikes in arterial wall stress by restricting blood pressure within a stable
range, and the clinical failure of celiprolol to actually alter the severe course of
complications once they have been initiated by breakthrough injury. The benefit of
celiprolol despite a physiologic effect opposite to what had been hypothesized (i.e., the
observed increase in mean blood pressure rather than a predicted lowering to
theoretically reduce stress on thin and overly weak arteries14) underscores the misleading
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nature of studying uninjured tissues in this disease. Physiological parameters measured
at baseline, which guided the design of this trial, apparently provide no predictive value
for risk of complication.
The longevity of the "tissue fragility" hypothesis4,160 obscures the assumptions
inherent to its logic, which include the assumption that type III collagen is necessary for
arterial wall strength, which has never been directly proven by mechanical testing.
Another assumption is the notion that wound healing suffers in vEDS patients because
the matrix in the organ wall is weaker13,14. Here we demonstrate the likelihood that the
matrix is actually stiffer, which is a conclusion long available from classic studies that
first characterized structurally enlarged fibers9, essentially stiffer fibers considering the
biochemistry of rigidly crosslinked polymers2, in the skin. This stiffness in the tissue is
critical to pathology such that weakness emerges from the inability of myofibroblasts to
effectively remodel stiffer tissue when necessary and must instead rely on their own
inherently unreliable contraction98. Thus, the scenario we are constructing here of
fibroproliferative pathology is paradoxical in that less matrix protein of one type leads to
stiffer bundles of another matrix protein, and that remodeling myofibroblasts take longer
to achieve stress-shielding, leading to a prolonged inflammatory granulation tissue, one
defining component of which--neovascularization--may confer the coups de grace of
true tissue fragility.
Despite the bias that pervades the tissue fragility hypothesis for vEDS patients,
observations made in a separate, less classifiable population further support a clinching
role for transmural neovascularization in the precipitation of vascular catastrophes.
Patients suffering from strokes at a premature age caused by cervical artery dissection
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already possess strong phenotypic overlap with vEDS patients16,39, but studies of their
connective tissue reveal further overlap in that abnormally structured collagen fibrils,
including increased diameters, as well as irregularly contoured surfaces or absent
banding patterns on electron microscopy, were observed in the skin. Furthermore,
immunogold labeling of type I and type III collagen on electron microscopy is increased
in abnormal sections of tissue161.
Since the initiation of this project, clinical researchers in this same group
obtained biopsies from superficial temporal arteries distant from the site of earlier
cervical artery dissection. Examination of the tissue revealed pathologic changes in
association with dissection that were common to all patients examined. These changes
were limited to the arterial media and adventitia, rather than appearing in the form of an
intimal tear as canonized in clinical dogma. Rather, researchers identified the abnormal
appearance of capillary neoangiogenesis penetrating the medial layer of vascular wall
and evidence of primary intramural microhematoma162-164. As these changes were
identified in arteries other than the sites of dissection, this new data suggests that
patients prone to spontaneous dissection and stroke possess an inherent and systemic
arteriopathy in the form of an abnormally increased burden of focal defects and,
critically, not in the form of a diffuse weakness attributable to the baseline elastic
properties of the vasculature162-164 (Figure 5.2).
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Figure 5.2. (a, b) Control subject exhibiting no pathology in the media or
adventitia. (c,d) Patient with prior history of spontaneous cervical artery dissection
demonstrating (c) a sickle-shaped microhematoma along the medial/adventitial
border and (d) severe capillary neoangiogenesis. Reprinted with permission from
Lippincott Williams & Wilkins [The outer arterial wall layers are primarily affected
in spontaneous cervical artery dissection. Volker W, Dittrich R, Grewe S, et al.
Neurology. 2011].
The benefit of this information is synergistic with that provided in the current
project, in that these studies associate neoangiogenesis with a prior, defined history of
risk for breach of arterial wall integrity. The most important contribution of this project
is the causative link between an initiating injury, which we experimentally induced, and
the subsequent pathologic inflammatory and fibroproliferative events involving
deranged matrix production that precipitate this neoangiogenesis. In our animal model,
uninjured mice otherwise appear identical to wild-type littermates in longevity, gross
arterial wall histology, and even arterial wall strength15,36.
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Future Directions
As this study hinges on the events occurring in the neointima, a vanishingly
small tissue contained within an elastic artery, a vastly different tissue whose relative
size threatens to wash out or confound any changes on whole-tissue biochemical assays,
exploitation of sophisticated NLOM imaging was critical to the conclusions at which we
have arrived. Above and beyond the simple mass of total collagen within a whole tissue
as measured by biochemical digestion, or the relative density visualized as a field of
collagen among histological structures via qualitative histochemical stains, NLOM
allowed us the direct and quantifiable observation of intact collagen fibers and the
structural parameters that determine their emergent mechanical properties. These
include fiber size and micro-orientation within the extracellular network in relation to
the resident cells responsible for their synthesis and remodeling, which more realistically
reflects the composite material properties of a dynamic tissue than dry collagen mass
alone98,165. Although electron microscopy allows the visualization of collagen fibers,
NLOM, unlike electron microscopy, provides field of view at the biologically-relevant
level of histological structure rather than single-cell ultrastructure, which is more useful
for making conclusions about the mechanical forces impinging on resident cells and the
mechanical properties acquired by the tissue as an effect of responsive remodeling98,112.
Further studies to test the hypothesis that impaired rates of type III collagen
secretion lead to remodeling of a stiffer tissue could involve NLOM and a "bioreactor"
cell culture system developed by our collaborator, Alvin T. Yeh, PhD166. Seeding of
mutant fibroblast cell lines into fibrin gels molded in a cruciate formation allows for
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rigging the gel to force transducers along two axes after the period of time over which
the cells remodel the matrix. Tension measurements to determine acquired stiffness of
the synthesized and organized matrix could dissect apart the contributions to mechanical
properties inherent the matrix itself from those generated by cellular contraction, if
measurements were made both before and after disruption of cellular contractile
filaments. Thus, the hypothesis that weakness of type III collagen-deficient matrix
originates in the excessive reliance on contraction by myofibroblasts and the failure of
stress-shielding, as suggested by our imaging, could be tested experimentally.
Other areas for future research include a more careful analysis of the conditions
for myofibroblast apoptosis in our fibrin gel constructs. Correlation between stress
shielding and programmed cell death108, or the lack thereof, would help explain not only
the persistently dysregulated proliferation of myofibroblasts in resolving thrombi but
also the oxygen and nutritional needs demanded by a constantly remodeling granulation
tissue and the prompting of persistent angiogenesis of fragile neovessels, much in the
nature of a growing tumor167. If stress shielding is truly the tipping point that initiates
apoptosis, COL3A1 mutant cells may never be able to overcome the challenges they face
in remodeling the matrix they synthesize.
Exciting but still controversial research on the role of bone marrow-derived
circulating "fibrocytes" in inflammatory and fibroproliferative pathology could open
new therapeutic options for vEDS patients and for patients vulnerable to sCAD168. It has
already been suggested that bone marrow-derived cells contribute to the bulk of cells
within neointimal lesions observed at relatively late timepoints following intravascular
injury169. Although studies performed since then have determined that the original
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burden of cells derived from bone marrow regresses so that long-term neointima
includes only locally-derived cells170, we have shown in this project that the critical
period for successful vs. pathologic vascular wound healing occurs much earlier. The
period encompassing granulation tissue expansion by matrix synthesis and compaction
by remodeling is mediated by fibrocellular neointima cells behaving more like
myofibroblasts than like quiescent smooth muscle cells74. So it may not matter that bone
marrow-derived fibrocytes disappear after maturation of neointima, in the paradigm of
wound healing supported by this project. In fact, this may be expected and purposeful, if
cells home to injured vessels and resulting thrombi, degrade fibrin and replace the lattice
with collagenous matrix, compact that matrix to lock in suitable tissue strength to gird
arteries weakened by injury, achieve tensional homeostasis and stress shielding, and then
die by apoptosis. Considering that vascular wound healing depends so heavily on
attracting circulating cells to a structure that itself is located in the circulation, it may
even be more plausible that the most critical steps in wound healing be enacted by
fibrocytes rather than by dedifferentiated smooth muscle cells, which would necessarily
need to degrade their own matrix first in order to migrate inward from the wall.
The particularly exciting possibility raised by the pathological mechanisms
elucidated in this project is the opportunity to replace circulating Col3a1+/- fibrocytes,
and by extension the deranged matrix they would produce, with type III collagensufficient bone marrow transplant. If the disease model suggested by the data in this
project is accurate, and if myofibroblasts responsible for wound healing in the arteries of
vEDS patients could instead produce normal matrix with physiologic material properties,
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then the predisposition to delayed thrombus resolution, fibroproliferative remodeling,
and risk for vascular catastrophe may in fact be curable.
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